Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
暂无分享,去创建一个
[1] F. Kuipers,et al. Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 P-glycoprotein-deficient mice. , 1998, Gastroenterology.
[2] S. Wright,et al. Interaction of 2,3-dimercapto-1-propane sulfonate with the human organic anion transporter hOAT1. , 2001, The Journal of pharmacology and experimental therapeutics.
[3] R. Angeletti,et al. The choroid plexus epithelium is the site of the organic anion transport protein in the brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] Y. Kokubo,et al. A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. , 2004, Kidney international.
[5] K. Kohno,et al. Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. , 1998, Biochemical and biophysical research communications.
[6] C. Paulusma,et al. Intestinal bile salt absorption in Atp8b1 deficient mice. , 2007, Journal of hepatology.
[7] B. Stieger,et al. Expression of the liver Na+-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. , 1997, Journal of hepatology.
[8] S. Masuda,et al. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. , 1998, The Journal of pharmacology and experimental therapeutics.
[9] P. Jansen,et al. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats , 2018 .
[10] D. Hipfner,et al. Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells. , 1997, Molecular pharmacology.
[11] J. Nezu,et al. Functional Characterization of Human Organic Anion Transporting Polypeptide B (OATP-B) in Comparison with Liver-Specific OATP-C , 2001, Pharmaceutical Research.
[12] A. V. van Herwaarden,et al. Sex-Dependent Expression and Activity of the ATP-Binding Cassette Transporter Breast Cancer Resistance Protein (BCRP/ABCG2) in Liver , 2005, Molecular Pharmacology.
[13] C. Klaassen,et al. Postnatal expression and induction by pregnenolone-16alpha-carbonitrile of the organic anion-transporting polypeptide 2 in rat liver. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[14] T. Abe,et al. Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] N. Mukhopadhyay,et al. Genetic Polymorphisms in Human Proton-Dependent Dipeptide Transporter PEPT1: Implications for the Functional Role of Pro586 , 2004, Journal of Pharmacology and Experimental Therapeutics.
[16] U. Schumacher,et al. Hyaluronan Export by the ABC Transporter MRP5 and Its Modulation by Intracellular cGMP* , 2007, Journal of Biological Chemistry.
[17] P. Dawson,et al. The Heteromeric Organic Solute Transporter α-β, Ostα-Ostβ, Is an Ileal Basolateral Bile Acid Transporter* , 2005, Journal of Biological Chemistry.
[18] M. Kool,et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. , 1997, Cancer research.
[19] P. Kwok,et al. Identification and Characterization of Proximal Promoter Polymorphisms in the Human Concentrative Nucleoside Transporter 2 (SLC28A2) , 2009, Journal of Pharmacology and Experimental Therapeutics.
[20] D. Keppler,et al. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. , 1999, Molecular pharmacology.
[21] V. Catania,et al. Hepatic Synthesis and Urinary Elimination of Acetaminophen Glucuronide Are Exacerbated in Bile Duct-Ligated Rats , 2008, Drug Metabolism and Disposition.
[22] R. Morris,et al. ROLE OF MRP2 IN THE HEPATIC DISPOSITION OF MYCOPHENOLIC ACID AND ITS GLUCURONIDE METABOLITES: EFFECT OF CYCLOSPORINE , 2006, Drug Metabolism and Disposition.
[23] F. Suchy,et al. Differential Developmental Regulation of Rat Liver Canalicular Membrane Transporters Bsep and Mrp2 , 2003, Pediatric Research.
[24] Piet Borst,et al. Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol , 2009, Molecular Pharmacology.
[25] R. Kim,et al. Transport of the sulfated, amidated bile acid, sulfolithocholyltaurine, into rat hepatocytes is mediated by Oatp1 and Oatp2 , 2002, Hepatology.
[26] R. Ueda,et al. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer. , 2009, Oncology reports.
[27] M. Dean,et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] C. Boyd,et al. Analysis of ABCC6 (MRP6) in normal human tissues , 2005, Histochemistry and Cell Biology.
[29] M. Noda,et al. Genetic variations of the ABC transporter gene ABCC3 in a Japanese population. , 2007, Drug metabolism and pharmacokinetics.
[30] J. Uitto,et al. Targeted ablation of Abcc1 or Abcc3 in Abcc6−/− mice does not modify the ectopic mineralization process , 2007, Experimental dermatology.
[31] J. Schuetz,et al. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs , 1999, Nature Medicine.
[32] T. Uchihashi,et al. Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines. , 2007, International journal of oncology.
[33] T. Horie,et al. Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[34] G. Koren,et al. Ontogeny of Renal P-glycoprotein Expression in Mice: Correlation with Digoxin Renal Clearance , 2005, Pediatric Research.
[35] K. Okumura,et al. Pressure Overload-Induced Cardiomyopathy in Heterozygous Carrier Mice of Carnitine Transporter Gene Mutation , 2007, Hypertension.
[36] S. Masuda,et al. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. , 2005, Drug metabolism and pharmacokinetics.
[37] C. Klaassen,et al. Regulation of hepatic transporters by xenobiotic receptors. , 2005, Current drug metabolism.
[38] Zhe-Sheng Chen,et al. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). , 2002, Cancer research.
[39] A. V. van Herwaarden,et al. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk. , 2006, Carcinogenesis.
[40] Y. Kikuchi,et al. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. , 2008, American journal of human genetics.
[41] D. Keppler,et al. Up‐regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver , 2001, Hepatology.
[42] Y. Sugiyama,et al. Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11 , 2005, Hepatology.
[43] P. Bosma,et al. Zonal down‐regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver , 2000, Hepatology.
[44] Fanfan Zhou,et al. Comparison of the Interaction of Human Organic Anion Transporter hOAT4 with PDZ Proteins between Kidney Cells and Placental Cells , 2008, Pharmaceutical Research.
[45] X. Xia,et al. Degradation of the Apical Sodium-dependent Bile Acid Transporter by the Ubiquitin-Proteasome Pathway in Cholangiocytes* , 2004, Journal of Biological Chemistry.
[46] H. Koepsell,et al. Membrane localization of the electrogenic cation transporter rOCT1 in rat liver. , 1998, Biochemical and biophysical research communications.
[47] E. Boerwinkle,et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout , 2009, Proceedings of the National Academy of Sciences.
[48] Thomas J. Raub,et al. Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice , 2007, Drug Metabolism and Disposition.
[49] Y. Kanai,et al. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. , 2001, Molecular pharmacology.
[50] R. Kim,et al. Naringin is a Major and Selective Clinical Inhibitor of Organic Anion‐Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice , 2007, Clinical pharmacology and therapeutics.
[51] V. Sasseville,et al. A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2) , 1999, The Journal of Biological Chemistry.
[52] F. O’Sullivan,et al. Simultaneous PET Imaging of P-Glycoprotein Inhibition in Multiple Tissues in the Pregnant Nonhuman Primate , 2009, Journal of Nuclear Medicine.
[53] C. Trautwein,et al. Hepatocyte nuclear factor-4 (cid:1) is a central transactivator of the mouse Ntcp gene , 2008 .
[54] Oliver Fiehn,et al. Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice. , 2007, Physiological genomics.
[55] Yusuke Nakamura,et al. A SNP in the ABCC11 gene is the determinant of human earwax type , 2006, Nature Genetics.
[56] A. Klein-Szanto,et al. Analysis of the In Vivo Functions of Mrp3 , 2005, Molecular Pharmacology.
[57] M. Vore,et al. The Role of Protein Synthesis and Degradation in the Post-Transcriptional Regulation of Rat Multidrug Resistance-Associated Protein 2 (Mrp2, Abcc2) , 2005, Molecular Pharmacology.
[58] P. A. Rea,et al. Transport of amphipathic anions by human multidrug resistance protein 3. , 2000, Cancer research.
[59] P. Meier,et al. Functional expression of the canalicular bile salt export pump of human liver. , 2002, Gastroenterology.
[60] H. Aburatani,et al. ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. , 2002, Biochemical and biophysical research communications.
[61] O. van Tellingen,et al. Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo , 2009, Clinical Cancer Research.
[62] M. Pastor-Anglada,et al. Role of CNT3 in the transepithelial flux of nucleosides and nucleoside‐derived drugs , 2007, The Journal of physiology.
[63] A. V. van Herwaarden,et al. The Breast Cancer Resistance Protein (BCRP/ABCG2) Affects Pharmacokinetics, Hepatobiliary Excretion, and Milk Secretion of the Antibiotic Nitrofurantoin , 2005, Molecular Pharmacology.
[64] P. Dawson,et al. The organic solute transporter α-β, Ostα-Ostβ, is essential for intestinal bile acid transport and homeostasis , 2008, Proceedings of the National Academy of Sciences.
[65] H. Saito,et al. Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney. , 1995, The Journal of pharmacology and experimental therapeutics.
[66] G. Burckhardt,et al. Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. , 2005, American journal of physiology. Cell physiology.
[67] L. Varticovski,et al. Mechanism by which cAMP activates PI3-kinase and increases bile acid secretion in WIF-B9 cells. , 2002, American journal of physiology. Cell physiology.
[68] H. Endou,et al. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. , 2002, The Journal of pharmacology and experimental therapeutics.
[69] J. Mackey,et al. Nucleoside transporters: molecular biology and implications for therapeutic development. , 1999, Molecular medicine today.
[70] R. Ho,et al. A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells. , 2006, Journal of pharmaceutical sciences.
[71] D. Keppler,et al. Prostanoid transport by multidrug resistance protein 4 (MRP4/ABCC4) localized in tissues of the human urogenital tract. , 2005, The Journal of urology.
[72] P. Meier,et al. Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver. , 2001, Gastroenterology.
[73] Yuichi Sugiyama,et al. Role of Breast Cancer Resistance Protein (Bcrp1/Abcg2) in the Extrusion of Glucuronide and Sulfate Conjugates from Enterocytes to Intestinal Lumen , 2005, Molecular Pharmacology.
[74] V. Ganapathy,et al. Carnitine Content and Expression of Mitochondrial β-Oxidation Enzymes in Placentas of Wild-Type (OCTN2+/+) and OCTN2 Null (OCTN2−/−) Mice , 2004, Pediatric Research.
[75] H. Yawo,et al. Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1* , 1999, The Journal of Biological Chemistry.
[76] C. Paulusma,et al. The type 4 subfamily of P-type ATPases, putative aminophospholipid translocases with a role in human disease. , 2005, Biochimica et biophysica acta.
[77] P. Dawson,et al. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. , 1994, The Journal of biological chemistry.
[78] D. Keppler,et al. Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2). , 2002, European journal of biochemistry.
[79] Y. Sugiyama,et al. Characterization of inducible nature of MRP3 in rat liver. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[80] P. Dawson,et al. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. , 1997, The Journal of clinical investigation.
[81] J. Unadkat,et al. FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620N , 2005, Drug Metabolism and Disposition.
[82] R. Kim,et al. Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans , 2007, Clinical pharmacology and therapeutics.
[83] L. Doyle,et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[84] S. Choudhuri,et al. Gender-specific and developmental influences on the expression of rat organic anion transporters. , 2002, The Journal of pharmacology and experimental therapeutics.
[85] N. Ballatori,et al. Heterodimerization, trafficking and membrane topology of the two proteins, Ostα and Ostβ, that constitute the organic solute and steroid transporter , 2007 .
[86] Y. Sugiyama,et al. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats. , 2000, The Journal of pharmacology and experimental therapeutics.
[87] Hassane Izzedine,et al. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. , 2006, The Journal of infectious diseases.
[88] P. Dawson,et al. Targeted Deletion of the Ileal Bile Acid Transporter Eliminates Enterohepatic Cycling of Bile Acids in Mice* , 2003, Journal of Biological Chemistry.
[89] C. Klaassen. Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides. , 1974, The Journal of pharmacology and experimental therapeutics.
[90] K. Toshimori,et al. Expression and distribution of OCTN2 in mouse epididymis and its association with obstructive azoospermia in juvenile visceral steatosis mice , 2006, International journal of urology : official journal of the Japanese Urological Association.
[91] R. Ho,et al. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells. , 2006, Journal of pharmaceutical sciences.
[92] B. Sarkadi,et al. Loss of ATP-dependent Transport Activity in Pseudoxanthoma Elasticum-associated Mutants of Human ABCC6 (MRP6)* , 2002, The Journal of Biological Chemistry.
[93] L. Gresh,et al. Characterization of the Human OATP-C (SLC21A6) Gene Promoter and Regulation of Liver-specific OATP Genes by Hepatocyte Nuclear Factor 1α* , 2001, The Journal of Biological Chemistry.
[94] D. Keppler,et al. Immunolocalization of multidrug resistance protein 5 in the human genitourinary system. , 2002, The Journal of urology.
[95] T. Gilliam,et al. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. , 1999, Human molecular genetics.
[96] Maristela L Onozato,et al. Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors. , 2004, European journal of pharmacology.
[97] Ning Li,et al. Tissue expression, ontogeny, and inducibility of rat organic anion transporting polypeptide 4. , 2002, The Journal of pharmacology and experimental therapeutics.
[98] S. Masuda,et al. Molecular Cloning, Functional Characterization and Tissue Distribution of Rat H+/Organic Cation Antiporter MATE1 , 2006, Pharmaceutical Research.
[99] S. Cisternino,et al. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. , 2004, Cancer research.
[100] S. Scherer,et al. A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5). , 2003, Biochemical and biophysical research communications.
[101] J. Kim,et al. Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. , 2000, The Biochemical journal.
[102] C. Klaassen. Immaturity of the newborn rat's hepatic excretory function for ouabain. , 1972, The Journal of pharmacology and experimental therapeutics.
[103] Y. Cheung,et al. MDR1, the blood–brain barrier transporter, is associated with Parkinson’s disease in ethnic Chinese , 2004, Journal of Medical Genetics.
[104] T. Welte,et al. Expression, Localisation and Functional Implications of the Transporter Protein PEPT2 in the Upper Respiratory Tract , 2008, Respiration.
[105] Yoshiro Saito,et al. Fourteen novel single nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation transporter (OCT2). , 2004, Drug metabolism and pharmacokinetics.
[106] J. Schellens,et al. Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1−/−/Mdr1a/1b−/− (triple-knockout) and wild-type mice , 2008, Molecular Cancer Therapeutics.
[107] R. O. Oude Elferink,et al. Increased serum concentrations of secondary bile salts during cholate feeding are due to coprophagy. A study with wild-type and Atp8b1-deficient mice. , 2006, Molecular pharmaceutics.
[108] Y. Kato,et al. PDZ Adaptor Protein PDZK2 Stimulates Transport Activity of Organic Cation/Carnitine Transporter OCTN2 by Modulating Cell Surface Expression , 2006, Drug Metabolism and Disposition.
[109] R. Vonk,et al. Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion. , 2000, Gastroenterology.
[110] W. Hait,et al. Regulation of the Stability of P-Glycoprotein by Ubiquitination , 2004, Molecular Pharmacology.
[111] A. Andriulli,et al. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. , 2006, World journal of gastroenterology.
[112] P. García-Miranda,et al. Developmental Maturation and Segmental Distribution of Rat Small Intestinal L-Carnitine Uptake , 2005, The Journal of Membrane Biology.
[113] J. Brouwers,et al. Targeted metabolomics identifies glucuronides of dietary phytoestrogens as a major class of MRP3 substrates in vivo. , 2009, Gastroenterology.
[114] Dieter Schrenk,et al. Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution , 2001, Journal of Human Genetics.
[115] Y. Sugiyama,et al. Short-Chain Ubiquitination Is Associated with the Degradation Rate of a Cell-Surface-Resident Bile Salt Export Pump (BSEP/ABCB11) , 2009, Molecular Pharmacology.
[116] David S. Miller,et al. Functional expression of renal organic anion transport in Xenopus laevis oocytes , 1992, Molecular and Cellular Biochemistry.
[117] K. Chiba,et al. A novel variant allele of OATP-C (SLCO1B1) found in a Japanese patient with pravastatin-induced myopathy. , 2004, Drug metabolism and pharmacokinetics.
[118] D. Keppler,et al. The canalicular multidrug resistance protein, cMRP/MRP2, a novel conjugate export pump expressed in the apical membrane of hepatocytes. , 1997, Advances in enzyme regulation.
[119] J. Testa,et al. Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. , 2001, Cancer letters.
[120] N. Longo,et al. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[121] M. Hediger,et al. Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney. , 1995, Biochimica et biophysica acta.
[122] P. Meier,et al. Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta. , 2002, The Journal of clinical endocrinology and metabolism.
[123] I. Lerer,et al. The H syndrome is caused by mutations in the nucleoside transporter hENT3. , 2008, American journal of human genetics.
[124] Jos H Beijnen,et al. P-Glycoprotein and Breast Cancer Resistance Protein: Two Dominant Transporters Working Together in Limiting the Brain Penetration of Topotecan , 2007, Clinical Cancer Research.
[125] F. Kuipers,et al. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. , 2001, The Journal of clinical investigation.
[126] M. Hediger,et al. Human Intestinal H+/Peptide Cotransporter , 1995, The Journal of Biological Chemistry.
[127] Y. Sugiyama,et al. Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5'-untranslated region and exon 28. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[128] D. Moore,et al. trans-Stilbene Oxide Induces Expression of Genes Involved in Metabolism and Transport in Mouse Liver via CAR and Nrf2 Transcription Factors , 2006, Molecular Pharmacology.
[129] G. Peters,et al. The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. , 2005, Cancer research.
[130] H. Daniel,et al. The Peptide Transporter PEPT2 is Targeted by the Protein Kinase SGK1 and the Scaffold Protein NHERF2 , 2008, Cellular Physiology and Biochemistry.
[131] Thomas J. Jones,et al. Combined loss of orphan receptors PXR and CAR heightens sensitivity to toxic bile acids in mice , 2005, Hepatology.
[132] Richard J. Thompson,et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. , 2008, Gastroenterology.
[133] Jos H. Beijnen,et al. Brain Accumulation of Dasatinib Is Restricted by P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) and Can Be Enhanced by Elacridar Treatment , 2009, Clinical Cancer Research.
[134] K. Faber,et al. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[135] Y. Kanai,et al. The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. , 1999, The Journal of pharmacology and experimental therapeutics.
[136] B. Dallapiccola,et al. Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study. , 2006, Inflammatory bowel diseases.
[137] I. Roninson,et al. Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. , 1995, Biochemistry.
[138] P. Swaan,et al. Membrane topology of human ASBT (SLC10A2) determined by dual label epitope insertion scanning mutagenesis. New evidence for seven transmembrane domains. , 2006, Biochemistry.
[139] S. Yao,et al. Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). , 1997, The American journal of physiology.
[140] R. Keep,et al. Impact of Genetic Knockout of PEPT2 on Cefadroxil Pharmacokinetics, Renal Tubular Reabsorption, and Brain Penetration in Mice , 2007, Drug Metabolism and Disposition.
[141] J. C. Baayen,et al. Localization of Breast Cancer Resistance Protein (BCRP) in Microvessel Endothelium of Human Control and Epileptic Brain , 2005, Epilepsia.
[142] C. Gartung,et al. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis , 2003, Hepatology.
[143] J. Schuetz,et al. The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme* , 2004, Journal of Biological Chemistry.
[144] J. Glavy,et al. Down-regulation by Extracellular ATP of Rat Hepatocyte Organic Anion Transport Is Mediated by Serine Phosphorylation of Oatp1* , 2000, The Journal of Biological Chemistry.
[145] H. Kusuhara,et al. Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain* , 1999, The Journal of Biological Chemistry.
[146] K. Motojima,et al. PPARα Agonists Positively and Negatively Regulate the Expression of Several Nutrient/Drug Transporters in Mouse Small Intestine , 2007 .
[147] H. Tilg,et al. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[148] R. Kerwin,et al. The Antidepressant Desipramine Requires the ABCB1 (Mdr1)-Type p-Glycoprotein to Upregulate the Glucocorticoid Receptor in Mice , 2007, Neuropsychopharmacology.
[149] B. Thorens,et al. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy , 2009, Proceedings of the National Academy of Sciences.
[150] T. Ishikawa,et al. Multidrug resistance-associated protein 9 (ABCC12) is present in mouse and boar sperm. , 2007, The Biochemical journal.
[151] Q. Garrett,et al. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium. , 2008, Investigative ophthalmology & visual science.
[152] H. Takanaga,et al. Localization of organic anion transporting polypeptide 3 (oatp3) in mouse brain parenchymal and capillary endothelial cells , 2004, Journal of neurochemistry.
[153] A. Jaiswal,et al. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[154] M. Komada,et al. Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2. , 2008, The Biochemical journal.
[155] T. Dale,et al. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk , 2005, Nature Medicine.
[156] N. Ballatori,et al. N-glycosylation controls functional activity of Oatp1, an organic anion transporter. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[157] C. Tse,et al. Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[158] K. Itoh,et al. Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. , 2003, The Biochemical journal.
[159] F. Lang,et al. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. , 1998, Molecular pharmacology.
[160] T. Pusl,et al. Intrahepatic cholestasis of pregnancy , 2007, Orphanet journal of rare diseases.
[161] J. Boyer,et al. Characterization of cloned rat liver Na(+)-bile acid cotransporter using peptide and fusion protein antibodies. , 1994, The American journal of physiology.
[162] R. Balling,et al. Targeted Disruption of the Peptide Transporter Pept2 Gene in Mice Defines Its Physiological Role in the Kidney , 2003, Molecular and Cellular Biology.
[163] Osamu Ogawa,et al. Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. , 2007, Biochemical pharmacology.
[164] H. Kusuhara,et al. Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha/beta. , 2008, The Journal of pharmacology and experimental therapeutics.
[165] H. Koepsell,et al. Drug excretion mediated by a new prototype of polyspecific transporter , 1994, Nature.
[166] Piet Borst,et al. MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine , 1996, Cell.
[167] S. Yao,et al. Molecular Cloning and Functional Characterization of Nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) Equilibrative Nucleoside Transporter Proteins (rENT1 and rENT2) from Rat Tissues* , 1997, The Journal of Biological Chemistry.
[168] T. Ohtsubo,et al. Disruption of mdr1a p-glycoprotein gene results in dysfunction of blood–inner ear barrier in mice , 2000, Brain Research.
[169] B. Sarkadi,et al. C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins. , 2003, Biochemical and biophysical research communications.
[170] N. Longo,et al. Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy , 2004, Journal of Inherited Metabolic Disease.
[171] Jonathan C. Cohen,et al. Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8 Published, JLR Papers in Press, June 1, 2005. DOI 10.1194/jlr.M500124-JLR200 , 2005, Journal of Lipid Research.
[172] J. Beijnen,et al. Multidrug Resistance Proteins 2 and 3 Provide Alternative Routes for Hepatic Excretion of Morphine-Glucuronides , 2007, Molecular Pharmacology.
[173] A. Groen,et al. The role of mdr2 P‐glycoprotein in hepatobiliary lipid transport , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[174] N. Nabulsi,et al. [11C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type mice. , 2005, Bioorganic & medicinal chemistry.
[175] V. Catania,et al. Shift from Biliary to Urinary Elimination of Acetaminophen-Glucuronide in Acetaminophen-Pretreated Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.
[176] P. Gros,et al. Structural and functional characterization of the mouse multidrug resistance gene family. , 1990, Bulletin du cancer.
[177] J. Peters,et al. Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[178] U. Brinkmann,et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[179] Y. Kanai,et al. Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. , 1999, Molecular pharmacology.
[180] V. Ganapathy,et al. Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. , 2000, American journal of physiology. Renal physiology.
[181] T. Merriman,et al. Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort , 2006, Immunology and cell biology.
[182] Alfred H. Schinkel,et al. BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2) TRANSPORTS FLUOROQUINOLONE ANTIBIOTICS AND AFFECTS THEIR ORAL AVAILABILITY, PHARMACOKINETICS, AND MILK SECRETION , 2006, Drug Metabolism and Disposition.
[183] E. Burchard,et al. Effects of Genetic Variation in the Novel Organic Cation Transporter, OCTN1, on the Renal Clearance of Gabapentin , 2008, Clinical pharmacology and therapeutics.
[184] S. Nielsen,et al. ATP7B copper-regulated traffic and association with the tight junctions: copper excretion into the bile. , 2008, Gastroenterology.
[185] R. Keep,et al. Peptide transporter 2 (PEPT2) expression in brain protects against 5‐aminolevulinic acid neurotoxicity , 2007, Journal of neurochemistry.
[186] A. Latiano,et al. Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases. , 2007, World journal of gastroenterology.
[187] D. H. Sweet,et al. Expression Cloning and Characterization of ROAT1 , 1997, The Journal of Biological Chemistry.
[188] M. Niemi,et al. Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin , 2006, Pharmacogenetics and genomics.
[189] C. Beglinger,et al. Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract. , 2005, Biochemical pharmacology.
[190] Steffen Bauer,et al. Evidence for Inverse Effects of OATP‐C (SLC21A6) *5 and *1b Haplotypes on Pravastatin Kinetics , 2004, Clinical pharmacology and therapeutics.
[191] T. Terasaki,et al. Roles of Inner Blood-Retinal Barrier Organic Anion Transporter 3 in the Vitreous/Retina-to-Blood Efflux Transport of p-Aminohippuric Acid, Benzylpenicillin, and 6-Mercaptopurine , 2009, Journal of Pharmacology and Experimental Therapeutics.
[192] D. Hipfner,et al. Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[193] C. Klaassen,et al. Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. , 2008, Toxicology and applied pharmacology.
[194] D. Rosskopf,et al. Uptake of Cardiovascular Drugs Into the Human Heart: Expression, Regulation, and Function of the Carnitine Transporter OCTN2 (SLC22A5) , 2006, Circulation.
[195] T. Kamisako,et al. Alteration of the expression of adenosine triphosphate‐binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis , 2005, Journal of gastroenterology and hepatology.
[196] Physiology, structure, and regulation of the cloned organic anion transporters. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[197] I. Arias,et al. Mdr 2 Knockout mice link biliary phospholipid deficiency with small bile duct destruction , 1994, Hepatology.
[198] I. Song,et al. Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[199] C. Gui,et al. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[200] K. Inui,et al. Hepatocyte nuclear factor-4 regulates the human organic anion transporter 1 gene in the kidney , 2007 .
[201] K. Peng,et al. Tissue and Cell Distribution of the Multidrug Resistance-Associated Protein (MRP) in Mouse Intestine and Kidney , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[202] C. Klaassen,et al. Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[203] A. Enomoto,et al. Novel liver‐specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate , 2007, Hepatology.
[204] P. Dawson,et al. Comparative analysis of the ontogeny of a sodium-dependent bile acid transporter in rat kidney and ileum. , 1996, The American journal of physiology.
[205] 中島 典子. Developmental Changes in Multispecific Organic Anion Transporter 1 (OAT1)Expression in the Rat Kidney , 2000 .
[206] J. Boyer,et al. Cellular localization and up‐regulation of multidrug resistance–associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver , 2001, Hepatology.
[207] K. Lesch,et al. Decreased anxiety in mice lacking the organic cation transporter 3 , 2009, Journal of Neural Transmission.
[208] C. Eaves,et al. Liver and marrow of adult mdr-1a/1b(-/-) mice show normal generation, function, and multi-tissue trafficking of primitive hematopoietic cells. , 2002, Experimental hematology.
[209] J. Shim,et al. Identification and Functional Characterization of Genetic Variants of Human Organic Cation Transporters in a Korean Population , 2007, Drug Metabolism and Disposition.
[210] S. Thorgeirsson,et al. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication , 1993, Hepatology.
[211] P. Meier,et al. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[212] Olivier Fardel,et al. Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes , 2006, Drug Metabolism and Disposition.
[213] M. Piquette-Miller,et al. Inflammatory Cytokines, but Not Bile Acids, Regulate Expression of Murine Hepatic Anion Transporters in Endotoxemia , 2002, Journal of Pharmacology and Experimental Therapeutics.
[214] K. Nagasawa,et al. Mouse equilibrative nucleoside transporter 2 (mENT2) transports nucleosides and purine nucleobases differing from human and rat ENT2. , 2007, Biological & pharmaceutical bulletin.
[215] J. Boyer,et al. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. , 2000, Gastroenterology.
[216] Y. Sugiyama,et al. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. , 1997, Cancer research.
[217] M. Oshimura,et al. FUNCTIONAL ASSESSMENT OF ABCG2 (BCRP) GENE POLYMORPHISMS TO PROTEIN EXPRESSION IN HUMAN PLACENTA , 2005, Drug Metabolism and Disposition.
[218] Mi-Hye Lee,et al. Molecular cloning, genomic organization, genetic variations, and characterization of murine sterolin genes Abcg5 and Abcg8. , 2002, Journal of lipid research.
[219] Y. Kanai,et al. Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. , 1999, Journal of the American Society of Nephrology : JASN.
[220] L. Lue,et al. ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ1–40 Peptides , 2009, The Journal of Neuroscience.
[221] F. Suchy,et al. Sorting of rat liver and ileal sodium-dependent bile acid transporters in polarized epithelial cells. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[222] P. Meier,et al. Characterization of the mouse bile salt export pump overexpressed in the baculovirus system , 2001, Hepatology.
[223] Christine Dreyer,et al. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.
[224] R. Kim,et al. Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. , 2000, Molecular pharmacology.
[225] R. Burk,et al. Immunologic distribution of an organic anion transport protein in rat liver and kidney. , 1996, The American journal of physiology.
[226] S. DeKosky,et al. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease , 2007, Neurobiology of Aging.
[227] S. Nyström,et al. Ontogenetic Development and Spatial Distribution of the Ileal Apical Sodium-Dependent Bile Acid Transporter and the Ileal Lipid-Binding Protein in ApoE Knockout and C57BL/6 Mice , 2002, Scandinavian journal of gastroenterology.
[228] W. Fung-Leung,et al. ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. , 2001, Gastroenterology.
[229] Y. Sugiyama,et al. Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[230] T. Miloh,et al. beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[231] C. Klaassen,et al. Tissue distribution and induction of the rat multidrug resistance-associated proteins 5 and 6. , 2006, Life sciences.
[232] H. Kotani,et al. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2 , 2004, International journal of cancer.
[233] T. Ludwig,et al. Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. , 2005, The American journal of pathology.
[234] Paul B Watkins,et al. Differential Inhibition of Rat and Human Na+-Dependent Taurocholate Cotransporting Polypeptide (NTCP/SLC10A1)by Bosentan: A Mechanism for Species Differences in Hepatotoxicity , 2007, Journal of Pharmacology and Experimental Therapeutics.
[235] G R Lankas,et al. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. , 1998, Reproductive toxicology.
[236] P. Jansen,et al. Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia. , 1989, The Journal of clinical investigation.
[237] R. Davey,et al. The anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line. , 1996, British Journal of Cancer.
[238] Conrad C. Huang,et al. The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics. , 2006, American journal of physiology. Renal physiology.
[239] N. Ballatori,et al. Heterodimerization, trafficking and membrane topology of the two proteins, Ost alpha and Ost beta, that constitute the organic solute and steroid transporter. , 2007, The Biochemical journal.
[240] N. Freimer,et al. A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. , 2004, Human molecular genetics.
[241] P. Olinga,et al. Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[242] D. Häussinger,et al. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: A novel mechanism of cholestasis , 2009, Hepatology.
[243] Xingguo Cheng,et al. Tissue Distribution, Gender-Divergent Expression, Ontogeny, and Chemical Induction of Multidrug Resistance Transporter Genes (Mdr1a, Mdr1b, Mdr2) in Mice , 2009, Drug Metabolism and Disposition.
[244] T. Thalhammer,et al. Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium , 2004, Laboratory Investigation.
[245] J. Schuetz,et al. Multidrug-resistance-associated protein 1 (Mrp1) is probably not required for murine Th cell activation. , 2006, International immunology.
[246] J. Kim,et al. Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta* , 2000, The Journal of Biological Chemistry.
[247] Sarfaraz Ahmad,et al. Transport of N-Acetylcysteine S-Conjugates of Methylmercury in Madin-Darby Canine Kidney Cells Stably Transfected with Human Isoform of Organic Anion Transporter 1 , 2005, Journal of Pharmacology and Experimental Therapeutics.
[248] Kaoru Kobayashi,et al. Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells , 2005, Pharmacogenetics and genomics.
[249] T. Cihlar,et al. The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. , 1999, Molecular pharmacology.
[250] I. Catalá,et al. Frequent expression of the multi‐drug resistance‐associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP‐21 monoclonal antibody in paraffin‐embedded material , 2002, The Journal of pathology.
[251] A. Kong,et al. Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.
[252] Liqi Lai,et al. Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. , 2002, The Biochemical journal.
[253] J. Nezu,et al. Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa. , 2007, Reproduction.
[254] Supratim Choudhuri,et al. Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[255] Min Goo Lee,et al. MRP2 haplotypes confer differential susceptibility to toxic liver injury , 2007, Pharmacogenetics and genomics.
[256] C. Stanley,et al. Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency. , 2002, Molecular genetics and metabolism.
[257] J. Schellens,et al. The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients. , 2005, Cancer research.
[258] D. Groneberg,et al. Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. , 2001, The American journal of pathology.
[259] J. H. Beijnen,et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.
[260] Y. Kanai,et al. Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions. , 2004, Biochemical and biophysical research communications.
[261] B. Müller-Myhsok,et al. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn’s disease , 2005, Gut.
[262] J. Boyer,et al. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[263] C. Klaassen,et al. TISSUE DISTRIBUTION OF CONCENTRATIVE AND EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS IN MALE AND FEMALE RATS AND MICE , 2004, Drug Metabolism and Disposition.
[264] I. Arias,et al. Transporters on Demand: Intracellular Reservoirs and Cycling of Bile Canalicular ABC Transporters* , 2006, Journal of Biological Chemistry.
[265] V. Ling,et al. Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. , 2005, Biochemistry.
[266] D. Hipfner,et al. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. , 1994, Cancer research.
[267] Thomas J. Raub,et al. Roles of P-Glycoprotein, Bcrp, and Mrp2 in Biliary Excretion of Spiramycin in Mice , 2007, Antimicrobial Agents and Chemotherapy.
[268] I. Coe,et al. Differential expression of human nucleoside transporters in normal and tumor tissue. , 2001, Biochemical and biophysical research communications.
[269] I. Kema,et al. Sitosterolemia in ABC-transporter G5-deficient mice is aggravated on activation of the liver-X receptor. , 2004, Gastroenterology.
[270] M. Orth,et al. SEVERE TANGIER DISEASE WITH A NOVEL ABCA1 GENE MUTATION , 2008, Neurology.
[271] A. Sparreboom,et al. Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin‐Induced Nephrotoxicity , 2009, Clinical pharmacology and therapeutics.
[272] S. Nigam,et al. Molecular Cloning and Characterization of NKT, a Gene Product Related to the Organic Cation Transporter Family That Is Almost Exclusively Expressed in the Kidney* , 1997, The Journal of Biological Chemistry.
[273] N. Ballatori,et al. Mercapturic acids (N-acetylcysteine S-conjugates) as endogenous substrates for the renal organic anion transporter-1. , 2001, Molecular pharmacology.
[274] C. Webster,et al. Role of Protein Phosphatases in Cyclic AMP-mediated Stimulation of Hepatic Na+/Taurocholate Cotransport* , 1998, The Journal of Biological Chemistry.
[275] H. Rosing,et al. Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into Milk , 2006, Molecular and Cellular Biology.
[276] P. Neuvonen,et al. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics , 2006, Pharmacogenetics and genomics.
[277] Braxton D Mitchell,et al. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish. , 2008, Arthritis and rheumatism.
[278] J. Martinez-Picado,et al. Interaction of Nucleoside Inhibitors of HIV-1 Reverse Transcriptase with the Concentrative Nucleoside Transporter-1 (Slc28A1) , 2004, Antiviral therapy.
[279] G. L. Youngblood,et al. Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20). , 2006, American journal of physiology. Renal physiology.
[280] C Roland Wolf,et al. Directional trans-epithelial transport of organic anions in porcine LLC-PK1 cells that co-express human OATP1B1 (OATP-C) and MRP2. , 2005, Biochemical pharmacology.
[281] T. Nakanishi,et al. Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. , 2004, Molecular pharmaceutics.
[282] M. Eichelbaum,et al. Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. , 2002, Pharmacogenetics.
[283] Hideyuki Saito,et al. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. , 2002, Journal of the American Society of Nephrology : JASN.
[284] M. Dean. The genetics of ATP-binding cassette transporters. , 2005, Methods in enzymology.
[285] R. Keep,et al. PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes , 2006, Brain Research.
[286] R. Roberts,et al. Ethnicity-dependent Polymorphism in Na+-taurocholate Cotransporting Polypeptide (SLC10A1) Reveals a Domain Critical for Bile Acid Substrate Recognition* , 2004, Journal of Biological Chemistry.
[287] C. Sensen,et al. Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux , 1999, The Lancet.
[288] S. Sookoian,et al. Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. , 2008, Journal of hepatology.
[289] G. Folkers,et al. Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. , 2002, Molecular endocrinology.
[290] Yusuke Nakamura,et al. Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel‐induced leukopenia , 2008, Cancer science.
[291] K. Inui,et al. Hepatocyte nuclear factor-4{alpha} regulates the human organic anion transporter 1 gene in the kidney. , 2007, American journal of physiology. Renal physiology.
[292] T. Litman,et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. , 1999, Cancer research.
[293] H. Koepsell,et al. Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation. , 2005, Journal of the American Society of Nephrology : JASN.
[294] N. Ballatori,et al. Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[295] K. Ueda,et al. The COP9 signalosome controls ubiquitinylation of ABCA1. , 2009, Biochemical and biophysical research communications.
[296] T. van der Poll,et al. Mice Lacking the Multidrug Resistance Protein 1 Are Resistant to Streptococcus pneumoniae-Induced Pneumonia1 , 2001, The Journal of Immunology.
[297] T. van der Velde-Koerts,et al. Structure of the human MDR3 gene and physical mapping of the human MDR locus. , 1991, The Journal of biological chemistry.
[298] J. Schellens,et al. Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.
[299] G. Aithal,et al. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes. , 2007, Gastroenterology.
[300] R. Angeletti,et al. Rat organic anion transporting protein 1A1 (Oatp1a1): purification and phosphopeptide assignment. , 2006, Biochemistry.
[301] R. Evans,et al. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[302] P. Duan,et al. Regulation of human organic anion transporter 1 by ANG II: involvement of protein kinase Calpha. , 2009, American journal of physiology. Endocrinology and metabolism.
[303] M. Rex-Haffner,et al. Functional differences in steroid sulfate uptake of organic anion transporter 4 (OAT4) and organic anion transporting polypeptide 2B1 (OATP2B1) in human placenta , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[304] W. Sadee,et al. Genetic Variants of the Human H+/Dipeptide Transporter PEPT2: Analysis of Haplotype Functions , 2004, Journal of Pharmacology and Experimental Therapeutics.
[305] R. Collins,et al. SLCO1B1 variants and statin-induced myopathy--a genomewide study. , 2008, The New England journal of medicine.
[306] I. Diamond,et al. Genomic organization and expression of the mouse equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporter 1 (ENT1) gene. , 2000, Biochemical and biophysical research communications.
[307] Y. Kanai,et al. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. , 1999, American journal of physiology. Renal physiology.
[308] V. Vallon,et al. Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. , 2008, American journal of physiology. Renal physiology.
[309] C. Cass,et al. Distribution of Equilibrative, Nitrobenzylthioinosine‐Sensitive Nucleoside Transporters (ENT1) in Brain , 1999, Journal of neurochemistry.
[310] K. Zatloukal,et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. , 2003, Gastroenterology.
[311] J. Knoll,et al. PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[312] H. Koepsell,et al. The SLC22 drug transporter family , 2004, Pflügers Archiv.
[313] P. Meier,et al. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3 , 2001, Pflügers Archiv.
[314] J. Itoh,et al. Two N-linked glycans are required to maintain the transport activity of the bile salt export pump (ABCB11) in MDCK II cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[315] V. Ganapathy,et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. , 1999, The Journal of pharmacology and experimental therapeutics.
[316] Curtis D. Klaassen,et al. INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER , 2005, Drug Metabolism and Disposition.
[317] H. Tomita,et al. Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[318] A. Wanner,et al. The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells. , 2007, The Journal of allergy and clinical immunology.
[319] R. Kanamoto,et al. Characterization of Cloned Mouse Na+/taurocholate Cotransporting Polypeptide by Transient Expression in COS-7 Cells , 2002, Bioscience, biotechnology, and biochemistry.
[320] S. Cole,et al. Involvement of NHERF1 in apical membrane localization of MRP4 in polarized kidney cells. , 2009, Biochemical and biophysical research communications.
[321] T. Langmann,et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.
[322] H. Daniel,et al. H+-peptide cotransport in the human bile duct epithelium cell line SK-ChA-1. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[323] X. Chu,et al. Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2) , 2006, Journal of Pharmacology and Experimental Therapeutics.
[324] H. Kusuhara,et al. Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha/beta and DNA methylation. , 2006, Molecular pharmacology.
[325] Jos H. Beijnen,et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein , 1997, Nature Medicine.
[326] P. Bosma,et al. Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene , 1996, Science.
[327] Yuichi Sugiyama,et al. Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of Phytoestrogens , 2007, Molecular Pharmacology.
[328] I. Pastan,et al. MRP8, A New Member of ABC Transporter Superfamily, Identified by EST Database Mining and Gene Prediction Program, Is Highly Expressed in Breast Cancer , 2001, Molecular medicine.
[329] Zhe-Sheng Chen,et al. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. , 2001, The Journal of biological chemistry.
[330] D. Keppler,et al. Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system , 2006, Neuroscience.
[331] G. Rappold,et al. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter , 1998, Nature Neuroscience.
[332] A. Aguzzi,et al. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. , 2000, The Journal of pharmacology and experimental therapeutics.
[333] S. Bornstein,et al. Molecular evidence of organic ion transporters in the rat adrenal cortex with adrenocorticotropin-regulated zonal expression. , 2003, Endocrinology.
[334] Adriana M. Torres,et al. Sex differences in p-aminohippuric acid transport in rat kidney: Role of membrane fluidity and expression of OAT1 , 2002, Molecular and Cellular Biochemistry.
[335] Dean P. Jones,et al. Role of the Multidrug Resistance Protein-1 in Hypertension and Vascular Dysfunction Caused by Angiotensin II , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[336] K. Zatloukal,et al. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. , 2006, Gastroenterology.
[337] T. Ishikawa,et al. MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[338] Rachel M. Bailey,et al. Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G. , 2007, American journal of physiology. Renal physiology.
[339] J. Petrick,et al. Importance of Hepatic Induction of Constitutive Androstane Receptor and Other Transcription Factors That Regulate Xenobiotic Metabolism and Transport , 2007, Drug Metabolism and Disposition.
[340] T. Ishikawa,et al. Genetic polymorphisms of human ABC transporter ABCG2: development of the standard method for functional validation of SNPs by using the Flp recombinase system. , 2006, Journal of experimental therapeutics & oncology.
[341] A. Groen,et al. The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females. , 1997, Journal of hepatology.
[342] Honggang Wang,et al. The Breast Cancer Resistance Protein (Bcrp1/Abcg2) Limits Fetal Distribution of Glyburide in the Pregnant Mouse: An Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study , 2007, Molecular Pharmacology.
[343] A. M. van der Bliek,et al. Sequence of mdr3 cDNA encoding a human P-glycoprotein. , 1988, Gene.
[344] V. Ganapathy,et al. Interaction of anionic cephalosporins with the intestinal and renal peptide transporters PEPT 1 and PEPT 2. , 1997, Biochimica et biophysica acta.
[345] Guorong Xu,et al. Faculty Opinions recommendation of The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis. , 2008 .
[346] Yuichi Sugiyama,et al. Involvement of Organic Cation Transporter 1 in Hepatic and Intestinal Distribution of Metformin , 2002, Journal of Pharmacology and Experimental Therapeutics.
[347] A. Enomoto,et al. Functional Characterization of Rat Organic Anion Transporter 5 (Slc22a19) at the Apical Membrane of Renal Proximal Tubules , 2005, Journal of Pharmacology and Experimental Therapeutics.
[348] Xingguo Cheng,et al. Endocrine Regulation of Gender-Divergent Mouse Organic Anion-Transporting Polypeptide (Oatp) Expression , 2006, Molecular Pharmacology.
[349] H. Kusuhara,et al. Regulation of Tissue-Specific Expression of the Human and Mouse Urate Transporter 1 Gene by Hepatocyte Nuclear Factor 1 α/β and DNA Methylation , 2007, Molecular Pharmacology.
[350] N. Maeda,et al. A mouse model of sitosterolemia : absence of Abcg 8 / sterolin-2 results in failure to secrete biliary cholesterol , 2004 .
[351] Yusuke Nakamura,et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis , 2003, Nature Genetics.
[352] D. Keppler,et al. Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs. , 2008, Expert opinion on drug metabolism & toxicology.
[353] P. Dawson,et al. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. , 2005, The Journal of biological chemistry.
[354] B. Stieger,et al. Bosentan Is a Substrate of Human OATP1B1 and OATP1B3: Inhibition of Hepatic Uptake as the Common Mechanism of Its Interactions with Cyclosporin A, Rifampicin, and Sildenafil , 2007, Drug Metabolism and Disposition.
[355] Richard J. Thompson,et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis , 1998, Nature Genetics.
[356] S. Tsuchida,et al. Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats1 , 2004, Transplantation.
[357] S. Strom,et al. ATPase Class I Type 8B Member 1 and Protein Kinase C ζ Induce the Expression of the Canalicular Bile Salt Export Pump in Human Hepatocytes , 2010, Pediatric Research.
[358] M. Sheng,et al. PDZ Domains: Structural Modules for Protein Complex Assembly* , 2002, The Journal of Biological Chemistry.
[359] J. Nezu,et al. Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[360] D. Barlow,et al. Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27. , 1999, Genomics.
[361] S. Ferdinandusse,et al. PPAR alpha-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. , 2007, Biochimica et biophysica acta.
[362] R. Evers,et al. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1 , 1997, FEBS letters.
[363] Y. Sugiyama,et al. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[364] P. Acott,et al. BRAIN CYCLOSPORIN A LEVELS ARE DETERMINED BY ONTOGENIC REGULATION OF MDR1A EXPRESSION , 2006, Drug Metabolism and Disposition.
[365] D. Häussinger,et al. Inborn errors of biliary canalicular transport systems. , 2005, Methods in enzymology.
[366] C. Gau,et al. Interaction between Anticonvulsants and Human Placental Carnitine Transporter , 2004, Epilepsia.
[367] D. Butterfield,et al. Mrp1 Localization and Function in Cardiac Mitochondria after Doxorubicin , 2009, Molecular Pharmacology.
[368] N. Ballatori,et al. Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione. , 2000, Molecular pharmacology.
[369] K. Faber,et al. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump , 2002, Hepatology.
[370] J. Schellens,et al. The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib , 2009, Investigational New Drugs.
[371] P. Meier,et al. Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[372] J. Willoughby,et al. PHYSIOLOGIC SECRETION OF GROWTH HORMONE AND PROLACTIN IN MALE AND FEMALE RATS , 1977, Clinical endocrinology.
[373] P. Dawson,et al. OSTα‐OSTβ: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia , 2005 .
[374] N. Longo,et al. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: Lack of genotype–phenotype correlation , 2000, Human mutation.
[375] J. Wijnholds,et al. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. , 2002, Molecular pharmacology.
[376] M. Trauner,et al. Hepatocyte nuclear factor-4alpha and bile acids regulate human concentrative nucleoside transporter-1 gene expression. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[377] T. Okada,et al. Experimental LPS‐induced cholestasis alters subcellular distribution and affects colocalization of Mrp2 and Bsep proteins: A quantitative colocalization study , 2005, Microscopy research and technique.
[378] T. Sugiyama,et al. Age-associated cardiomyopathy in heterozygous carrier mice of a pathological mutation of carnitine transporter gene, OCTN2. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.
[379] R. Kerwin,et al. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters , 2001, British journal of pharmacology.
[380] Richard J. Thompson,et al. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy , 2008, Gut.
[381] Y. Sugiyama,et al. Transfected Rat cMOAT Is Functionally Expressed on the Apical Membrane in Madin-Darby Canine Kidney (MDCK) Cells , 1998, Pharmaceutical Research.
[382] Joanne Wang,et al. Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. , 2007, American journal of physiology. Renal physiology.
[383] S. Cole,et al. Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1) , 2005, Pharmacogenetics and genomics.
[384] J. Miquel,et al. Localization of the Sodium-Taurocholate cotransporting polypeptide in membrane rafts and modulation of its activity by cholesterol in vitro. , 2008, Biochimica et biophysica acta.
[385] S. Kliewer,et al. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. , 2002, Molecular pharmacology.
[386] P. Meier,et al. Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump. , 2008, World journal of gastroenterology.
[387] Fanfan Zhou,et al. Role of Glycosylation in the Organic Anion Transporter OAT1* , 2004, Journal of Biological Chemistry.
[388] D. Keppler,et al. Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3). , 2004, Pharmacogenetics.
[389] I Meineke,et al. The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin , 2009, Clinical pharmacology and therapeutics.
[390] N. Ballatori,et al. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[391] Jonathan C. Cohen,et al. Selective sterol accumulation in ABCG5/ABCG8-deficient mice Published, JLR Papers in Press, December 1, 2003. DOI 10.1194/jlr.M300377-JLR200 , 2004, Journal of Lipid Research.
[392] L. Mangravite,et al. Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells. , 2003, American journal of physiology. Renal physiology.
[393] J. Boyer,et al. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. , 2001, Gastroenterology.
[394] R. Keep,et al. Role and Relevance of Peptide Transporter 2 (PEPT2) in the Kidney and Choroid Plexus: In Vivo Studies with Glycylsarcosine in Wild-Type and PEPT2 Knockout Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.
[395] G. Scheffer,et al. Induction of Hepatobiliary Efflux Transporters in Acetaminophen-Induced Acute Liver Failure Cases , 2007, Drug Metabolism and Disposition.
[396] P. Dawson,et al. Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine , 2002, Clinical pharmacology and therapeutics.
[397] M. Kool,et al. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. , 2000, Cancer research.
[398] Joseph W. Polli,et al. An Unexpected Synergist Role of P-Glycoprotein and Breast Cancer Resistance Protein on the Central Nervous System Penetration of the Tyrosine Kinase Inhibitor Lapatinib (N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016) , 2009, Drug Metabolism and Disposition.
[399] Praveen M. Bahadduri,et al. Functional characterization of the peptide transporter PEPT2 in primary cultures of human upper airway epithelium. , 2005, American journal of respiratory cell and molecular biology.
[400] T. Hasegawa,et al. Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice , 2005, Neuroscience Letters.
[401] Y. Kanai,et al. Posttranslational regulation of Abcc2 expression by SUMOylation system. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[402] I. Hyodo,et al. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[403] Y. Sugiyama,et al. 4‐phenylbutyrate enhances the cell surface expression and the transport capacity of wild‐type and mutated bile salt export pumps , 2007, Hepatology.
[404] P. Meier,et al. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. , 1995, Gastroenterology.
[405] R. Kim,et al. Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants , 2007, Pharmacogenetics and genomics.
[406] A. Tomoda,et al. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes , 2006, Journal of neurochemistry.
[407] J. Renfro,et al. Avian renal proximal tubule epithelium urate secretion is mediated by Mrp4. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[408] A. Dahan,et al. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[409] Yurong Lai,et al. Mitochondrial Expression of the Human Equilibrative Nucleoside Transporter 1 (hENT1) Results in Enhanced Mitochondrial Toxicity of Antiviral Drugs* , 2004, Journal of Biological Chemistry.
[410] H. Kusuhara,et al. Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[411] H. Glaeser,et al. Variability in human hepatic MRP4 expression: influence of cholestasis and genotype , 2008, The Pharmacogenomics Journal.
[412] Adam L VanWert,et al. Organic Anion Transporter 3 (Oat3/Slc22a8) Interacts with Carboxyfluoroquinolones, and Deletion Increases Systemic Exposure to Ciprofloxacin , 2008, Molecular Pharmacology.
[413] I. Arias,et al. Primary Structure and Functional Expression of a cDNA Encoding the Bile Canalicular, Purine-specific Na+-Nucleoside Cotransporter (*) , 1995, The Journal of Biological Chemistry.
[414] H. Brewer,et al. The ABCA1 transporter functions on the basolateral surface of hepatocytes. , 2002, Biochemical and biophysical research communications.
[415] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[416] M. Okuda,et al. Genetic variant Arg57His in human H+/peptide cotransporter 2 causes a complete loss of transport function. , 2004, Biochemical and biophysical research communications.
[417] S. Misra,et al. Familial intrahepatic cholestasis 1: Studies of localization and function , 2001, Hepatology.
[418] H. Daniel,et al. Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells. , 1996, The Journal of pharmacology and experimental therapeutics.
[419] H. Kroemer,et al. Organic Anion Transporting Polypeptide 2B1 and Breast Cancer Resistance Protein Interact in the Transepithelial Transport of Steroid Sulfates in Human Placenta , 2007, Drug Metabolism and Disposition.
[420] G. Sachs,et al. Topography of the membrane domain of the liver Na+-dependent bile acid transporter. , 2005, Biochemistry.
[421] J. Nezu,et al. Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. , 2001, Biochimica et biophysica acta.
[422] I. Tamai,et al. Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha. , 2008, Biological & pharmaceutical bulletin.
[423] Qiang Zhang,et al. Organic Anion Transporter OAT1 Undergoes Constitutive and Protein Kinase C-regulated Trafficking through a Dynamin- and Clathrin-dependent Pathway* , 2008, Journal of Biological Chemistry.
[424] H. Kroemer,et al. The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. , 2004, Blood.
[425] A. Enomoto,et al. The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia , 2004, Pediatric Nephrology.
[426] P. Meier,et al. Differential effects of microsomal enzyme–inducing chemicals on the hepatic expression of rat organic anion transporters, OATP1 and OATP2 , 2001, Hepatology.
[427] S. Vavricka,et al. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver , 2002, Hepatology.
[428] Hirotaka Matsuo,et al. Molecular identification of a renal urate–anion exchanger that regulates blood urate levels , 2002, Nature.
[429] Ying Zhang,et al. PKC regulation of the human equilibrative nucleoside transporter, hENT1 , 2002, FEBS letters.
[430] C. Aquilante,et al. Clinical and Genetic Determinants of Intracellular Tenofovir Diphosphate Concentrations in HIV-Infected Patients , 2008, Journal of acquired immune deficiency syndromes.
[431] R. W. Daniel,et al. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[432] I. Tamai,et al. Organic anion transporters. , 1999, Pharmaceutical biotechnology.
[433] J. Boyer,et al. Functional Complementation between a Novel Mammalian Polygenic Transport Complex and an Evolutionarily Ancient Organic Solute Transporter, OSTα-OSTβ* , 2003, Journal of Biological Chemistry.
[434] S. T. Hwang,et al. Ontogenic Regulation of Components of Ileal Bile Acid Absorption , 2001, Experimental biology and medicine.
[435] P. Neuvonen,et al. ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin , 2009, Clinical pharmacology and therapeutics.
[436] D. Keppler,et al. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[437] J. Boyer,et al. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTα-OSTβ in cholestasis in humans and rodents , 2006 .
[438] M. Kool,et al. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. , 1999, Cancer research.
[439] D. Postma,et al. Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice , 2007, Respiratory research.
[440] R. Kim,et al. Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/Slco1b2) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin , 2008, Molecular Pharmacology.
[441] M. Gazouli,et al. Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease. , 2005, World journal of gastroenterology.
[442] C. Cass,et al. Immunocytochemical Demonstration of the Equilibrative Nucleoside Transporter rENT1 in Rat Sinoatrial Node , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[443] Shufeng Zhou,et al. Human Multidrug Resistance Associated Protein 4 Confers Resistance to Camptothecins , 2005, Pharmaceutical Research.
[444] S. Krähenbühl,et al. Effect of Carnitine Deprivation on Carnitine Homeostasis and Energy Metabolism in Mice with Systemic Carnitine Deficiency , 2008, Annals of Nutrition and Metabolism.
[445] P. Borst,et al. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. , 1991, Cancer research.
[446] Didier Raoult,et al. Molecular identification by , 2000 .
[447] C. Gui,et al. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. , 2008, European journal of pharmacology.
[448] Allard C van der Wal,et al. Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. , 2005, Human molecular genetics.
[449] L. Barbot,et al. The regionalization of PepT1, NBAT and EAAC1 transporters in the small intestine of rats are unchanged from birth to adulthood. , 2002, The Journal of nutrition.
[450] V. Ganapathy,et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. , 2000, Biochimica et biophysica acta.
[451] D. Beier,et al. Regulation of hepatocyte bile salt transporters during hepatic regeneration. , 1997, The American journal of physiology.
[452] R. Keep,et al. Role of PEPT2 in peptide/mimetic trafficking at the blood-cerebrospinal fluid barrier: studies in rat choroid plexus epithelial cells in primary culture. , 2002, The Journal of pharmacology and experimental therapeutics.
[453] C. Handschin,et al. Induction of drug metabolism: the role of nuclear receptors. , 2008, Pharmacological reviews.
[454] Xingguo Cheng,et al. TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS) , 2005, Drug Metabolism and Disposition.
[455] H. Groen,et al. The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours. , 2004, European journal of cancer.
[456] C. Cass,et al. Distribution and Functional Characterization of Equilibrative Nucleoside Transporter-4, a Novel Cardiac Adenosine Transporter Activated at Acidic pH , 2006, Circulation research.
[457] A. Slitt,et al. Induction of drug metabolism enzymes and transporters by oltipraz in rats , 2008, Journal of biochemical and molecular toxicology.
[458] P. Borst,et al. Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter. , 2003, The Biochemical journal.
[459] P. Meier,et al. The superfamily of organic anion transporting polypeptides. , 2003, Biochimica et biophysica acta.
[460] T. Kiss,et al. P-glycoprotein inhibition by membrane cholesterol modulation. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[461] M. Anwer,et al. Dephosphorylation of Ser-226 Facilitates Plasma Membrane Retention of Ntcp* , 2005, Journal of Biological Chemistry.
[462] I. Tamai,et al. Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells. , 2005, Reproduction.
[463] Y. Tanaka,et al. Hormonal regulation of renal multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) in mice. , 2006, Biochemical pharmacology.
[464] C. Klaassen,et al. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. , 2002, The Journal of pharmacology and experimental therapeutics.
[465] A. Groen,et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. , 1994, The American journal of pathology.
[466] H. Koepsell,et al. Localization of organic cation transporters OCT1 and OCT2 in rat kidney. , 2000, American journal of physiology. Renal physiology.
[467] D. Oh,et al. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition , 2004, Clinical pharmacology and therapeutics.
[468] M. Dean,et al. Degeneration of an ATP-binding cassette transporter gene, ABCC13, in different mammalian lineages. , 2004, Genomics.
[469] P. Meier,et al. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver , 1997, Hepatology.
[470] S. Masuda,et al. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. , 2007, Biochemical pharmacology.
[471] O. Fiehn,et al. High Copper Selectively Alters Lipid Metabolism and Cell Cycle Machinery in the Mouse Model of Wilson Disease* , 2007, Journal of Biological Chemistry.
[472] R. Wanders,et al. Silent and symptomatic primary carnitine deficiency within the same family due toidentical mutations in the organic cation/carnitine transporter OCTN2 , 2003, Journal of Inherited Metabolic Disease.
[473] G. Dalmasso,et al. Association of PepT1 with lipid rafts differently modulates its transport activity in polarized and nonpolarized cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[474] H. Saito,et al. Hormonal regulation of organic cation transporter OCT2 expression in rat kidney , 2000, FEBS letters.
[475] H. Koepsell,et al. Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases. , 2003, American journal of physiology. Renal physiology.
[476] Y. Liu,et al. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[477] A. Lamhonwah,et al. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. , 2006, Biochemical and biophysical research communications.
[478] V. Ganapathy,et al. Mutations in Novel Organic Cation Transporter (OCTN2), an Organic Cation/Carnitine Transporter, with Differential Effects on the Organic Cation Transport Function and the Carnitine Transport Function* , 1999, The Journal of Biological Chemistry.
[479] P. Meier,et al. The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver* , 1998, The Journal of Biological Chemistry.
[480] Yuichi Sugiyama,et al. Improvement of the Oral Drug Absorption of Topotecan through the Inhibition of Intestinal Xenobiotic Efflux Transporter, Breast Cancer Resistance Protein, by Excipients , 2007, Drug Metabolism and Disposition.
[481] V. Ling,et al. Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein. , 1998, Cancer research.
[482] S. Bates,et al. Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2* , 2004, Journal of Biological Chemistry.
[483] U. Hofmann,et al. Characterisation of cerivastatin as a P-glycoprotein substrate: studies in P-glycoprotein-expressing cell monolayers and mdr1a/b knock-out mice , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[484] S. Wright,et al. Acute regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules. , 2004, American journal of physiology. Renal physiology.
[485] Shuzhong Zhang,et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. , 2007, The Journal of clinical investigation.
[486] J. Peppercorn,et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene , 1993, Nature Genetics.
[487] M. Flens,et al. Tissue distribution of the multidrug resistance protein. , 1996, The American journal of pathology.
[488] C. Guillemette,et al. Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. , 2008, Pharmacogenomics.
[489] Stephen H Wright,et al. Functional influence of N-glycosylation in OCT2-mediated tetraethylammonium transport. , 2006, American journal of physiology. Renal physiology.
[490] A. Wolkoff,et al. Topological assessment of oatp1a1: a 12-transmembrane domain integral membrane protein with three N-linked carbohydrate chains. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[491] J. Uitto,et al. Identification of ABCC6 pseudogenes on human chromosome 16p: implications for mutation detection in pseudoxanthoma elasticum , 2001, Human Genetics.
[492] J. Boyer,et al. Molecular identification and functional characterization of Mdr1a in rat cholangiocytes. , 2000, Gastroenterology.
[493] J. Lippincott-Schwartz,et al. Rab11a and myosin Vb are required for bile canalicular formation in WIF-B9 cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[494] S. D. de Morais,et al. Utility of a Novel Oatp1b2 Knockout Mouse Model for Evaluating the Role of Oatp1b2 in the Hepatic Uptake of Model Compounds , 2008, Drug Metabolism and Disposition.
[495] W. Sadee,et al. Genetic Variants of the Human Dipeptide Transporter PEPT1 , 2006, Journal of Pharmacology and Experimental Therapeutics.
[496] T. Ishikawa,et al. Evidence for leukotriene C4 transport mediated by an ATP‐dependent glutathione S‐conjugate carrier in rat heart and liver plasma membranes , 1989, FEBS letters.
[497] Huey-Ling Chen,et al. Compensatory role of P‐glycoproteins in knockout mice lacking the bile salt export pump , 2009, Hepatology.
[498] E. Schömig,et al. Increased ergothioneine tissue concentrations in carriers of the Crohn’s disease risk-associated 503F variant of the organic cation transporter OCTN1 , 2009, Gut.
[499] Y. Sugiyama,et al. Characterization of the Cellular Localization, Expression Level, and Function of SNP Variants of MRP2/ABCC2 , 2004, Pharmaceutical Research.
[500] Jin-Ming Yang,et al. Interaction between CD147 and P-Glycoprotein and Their Regulation by Ubiquitination in Breast Cancer Cells , 2008, Chemotherapy.
[501] M. Fromm,et al. Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. , 2004, Pharmacogenetics.
[502] S. Wright,et al. Molecular identification and functional characterization of rabbit MATE1 and MATE2-K. , 2007, American journal of physiology. Renal physiology.
[503] C. Klaassen,et al. Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. , 2004, Biochemical and biophysical research communications.
[504] T. J. Cook,et al. Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 In Vitro cell culture model, and multiple human tissues , 2001, AAPS PharmSci.
[505] M. Stoffel,et al. Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism , 2001, Nature Genetics.
[506] M. Uhr,et al. Penetration of Endogenous Steroid Hormones Corticosterone, Cortisol, Aldosterone and Progesterone into the Brain is Enhanced in Mice Deficient for Both mdr1a and mdr1b P‐Glycoproteins , 2002, Journal of neuroendocrinology.
[507] H. Seguchi,et al. Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[508] T. Litman,et al. Identification of Intra- and Intermolecular Disulfide Bridges in the Multidrug Resistance Transporter ABCG2* , 2005, Journal of Biological Chemistry.
[509] P. Meier,et al. Expression of members of the multidrug resistance protein family in human term placenta. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[510] B. Jégou,et al. Multidrug Resistance Genes and P-Glycoprotein in the Testis of the Rat, Mouse, Guinea Pig, and Human1 , 2002, Biology of reproduction.
[511] K. Shimokata,et al. Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia. , 2001, Pharmacogenetics.
[512] Richard J. Thompson,et al. The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. , 2002, Gastroenterology.
[513] Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease , 2005, Gut.
[514] C. R. Crawford,et al. Cloning of the Human Equilibrative, Nitrobenzylmercaptopurine Riboside (NBMPR)-insensitive Nucleoside Transporter ei by Functional Expression in a Transport-deficient Cell Line* , 1998, The Journal of Biological Chemistry.
[515] H. Kao,et al. cDNA cloning and genomic organization of the murine MRP7, a new ATP-binding cassette transporter. , 2002, Gene.
[516] R. Evers,et al. Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP , 1996, FEBS letters.
[517] C. Klaassen,et al. Protein kinase C suppresses rat organic anion transporting polypeptide 1- and 2-mediated uptake. , 2001, The Journal of pharmacology and experimental therapeutics.
[518] J. Schuetz,et al. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[519] P. Meier,et al. Differential expression of bile salt and organic anion transporters in developing rat liver. , 2004, Journal of hepatology.
[520] S. Nigam,et al. Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues , 2007, Nature Clinical Practice Nephrology.
[521] O. Gavrilova,et al. In vivo relevance of Mrp2-mediated biliary excretion of the Amanita mushroom toxin demethylphalloin. , 2007, Biochimica et biophysica acta.
[522] E. Burchard,et al. Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin , 2009, Pharmacogenetics and genomics.
[523] T. Fujita,et al. Effects of structure on binding to the 2,3,7,8-TCDD receptor protein and AHH induction--halogenated biphenyls. , 1985, Environmental health perspectives.
[524] D. Postma,et al. Multidrug resistance related molecules in human and murine lung. , 2002, Journal of clinical pathology.
[525] Y. Sugiyama,et al. Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil , 2004, Journal of Pharmacology and Experimental Therapeutics.
[526] G. L. Youngblood,et al. Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. , 2004, American journal of physiology. Renal physiology.
[527] I. Arias,et al. Hormonal regulation of hepatic multidrug resistance-associated protein 2 (Abcc2) primarily involves the pattern of growth hormone secretion. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[528] S. Wright,et al. Sex Differences in the mRNA, Protein, and Functional Expression of Organic Anion Transporter (Oat) 1, Oat3, and Organic Cation Transporter (Oct) 2 in Rabbit Renal Proximal Tubules , 2006, Journal of Pharmacology and Experimental Therapeutics.
[529] A. Enomoto,et al. Role of human organic anion transporter 4 in the transport of ochratoxin A. , 2002, Biochimica et biophysica acta.
[530] N. Ballatori,et al. Identification of a mechanism by which the methylmercury antidotes N-acetylcysteine and dimercaptopropanesulfonate enhance urinary metal excretion: transport by the renal organic anion transporter-1. , 2002, Molecular pharmacology.
[531] Fanfan Zhou,et al. Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[532] P. Dawson,et al. OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. , 2005, Hepatology.
[533] O. van Tellingen,et al. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. , 1999, The Journal of clinical investigation.
[534] I. Tamai,et al. Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice. , 1999, Journal of pharmaceutical sciences.
[535] Jian Yang,et al. Oxysterol 22(R)-Hydroxycholesterol Induces the Expression of the Bile Salt Export Pump through Nuclear Receptor Farsenoid X Receptor but Not Liver X Receptor , 2006, Journal of Pharmacology and Experimental Therapeutics.
[536] C. Endres,et al. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[537] D. Besselsen,et al. Efflux Transporter Expression and Acetaminophen Metabolite Excretion Are Altered in Rodent Models of Nonalcoholic Fatty Liver Disease , 2007, Drug Metabolism and Disposition.
[538] T. Langmann,et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.
[539] H. Daniel,et al. Functional expression of the peptide transporter PEPT2 in the mammalian enteric nervous system , 2005, The Journal of comparative neurology.
[540] C. Klaassen,et al. Endocrine regulation of rat organic anion transporters. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[541] J. Manautou,et al. Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[542] C. Higgins,et al. Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis* , 1997, The Journal of Biological Chemistry.
[543] M. Barrand,et al. A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. , 1994, Journal of the National Cancer Institute.
[544] Yuichi Sugiyama,et al. Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir , 2007, Molecular Pharmacology.
[545] J. Uitto,et al. Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms , 2009, Experimental dermatology.
[546] Shuzhong Zhang,et al. Transport of Paraquat by Human Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Family , 2007, Journal of Pharmacology and Experimental Therapeutics.
[547] Masahiko Watanabe,et al. Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte‐derived soluble factor(s) , 2004, Journal of neurochemistry.
[548] A. Parkinson,et al. Regulation of drug transporter gene expression by nuclear receptors. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[549] Y. Sawada,et al. Functional Analysis of Organic Cation Transporter 3 Expressed in Human Placenta , 2005, Journal of Pharmacology and Experimental Therapeutics.
[550] Sarfaraz Ahmad,et al. Handling of the Homocysteine S-Conjugate of Methylmercury by Renal Epithelial Cells: Role of Organic Anion Transporter 1 and Amino Acid Transporters , 2005, Journal of Pharmacology and Experimental Therapeutics.
[551] A. Sartorelli,et al. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[552] M. Donovan,et al. Role of organic cation transporters in dopamine uptake across olfactory and nasal respiratory tissues. , 2007, Molecular pharmaceutics.
[553] S. Bates,et al. ABCG2-mediated transport of photosensitizers: Potential impact on photodynamic therapy , 2005, Cancer biology & therapy.
[554] J. Uitto,et al. Elevated dietary magnesium prevents connective tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6(-/-)). , 2009, The Journal of investigative dermatology.
[555] M. Karin,et al. Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis , 2007, Drug Metabolism and Disposition.
[556] M. Relling,et al. Transporter-mediated protection against thiopurine-induced hematopoietic toxicity. , 2008, Cancer Research.
[557] A. Hutchinson,et al. Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. , 2001, Gene.
[558] K. Bock,et al. Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention. , 2006, Biochemical pharmacology.
[559] P. Meier,et al. Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[560] S. Terry,et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum , 2000, Nature Genetics.
[561] M Dietel,et al. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. , 1999, Journal of the National Cancer Institute.
[562] P. Pávek,et al. Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat. , 2008, Toxicology letters.
[563] J. Boyer,et al. Nuclear factor erythroid 2–related factor 2 is a positive regulator of human bile salt export pump expression , 2009, Hepatology.
[564] Katsuhisa Inoue,et al. Molecular Identification and Functional Characterization of Rat Multidrug and Toxin Extrusion Type Transporter 1 as an Organic Cation/H+ Antiporter in the Kidney , 2006, Drug Metabolism and Disposition.
[565] P. Meier,et al. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury , 2007, Pharmacogenetics and genomics.
[566] T. Ishikawa,et al. Quality control of human ABCG2 protein in the endoplasmic reticulum: ubiquitination and proteasomal degradation. , 2009, Advanced drug delivery reviews.
[567] T. Ishikawa,et al. Re‐evaluation and functional classification of non‐synonymous single nucleotide polymorphisms of the human ATP‐binding cassette transporter ABCG2 , 2007, Cancer science.
[568] H. Tomita,et al. Distribution of rat organic anion transporting polypeptide-E (oatp-E) in the rat eye. , 2003, Investigative ophthalmology & visual science.
[569] K. Yoshinari,et al. Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA. , 2007, Drug metabolism and pharmacokinetics.
[570] Markus Grube,et al. EXPRESSION, LOCALIZATION, AND FUNCTION OF THE CARNITINE TRANSPORTER OCTN2 (SLC22A5) IN HUMAN PLACENTA , 2005, Drug Metabolism and Disposition.
[571] P. Borst,et al. Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.
[572] Daying Zhang,et al. Ontogeny of Expression of Organic Anion Transporters 1 and 3 in Ovine Fetal and Neonatal Kidney , 2005, Experimental biology and medicine.
[573] P. Meier,et al. Transport function and hepatocellular localization of mrp6 in rat liver. , 2000, Molecular pharmacology.
[574] K. Toshimori,et al. Expression of novel organic cation/carnitine transporter (OCTN2) in the mouse pancreas. , 2005, Tissue & cell.
[575] L. Benet,et al. Effect of OATP1B Transporter Inhibition on the Pharmacokinetics of Atorvastatin in Healthy Volunteers , 2007, Clinical pharmacology and therapeutics.
[576] R. Evans,et al. The Constitutive Androstane Receptor and Pregnane X Receptor Function Coordinately to Prevent Bile Acid-induced Hepatotoxicity* , 2004, Journal of Biological Chemistry.
[577] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[578] P. Gros,et al. Phosphatidylcholine translocase: A physiological role for the mdr2 gene , 1994, Cell.
[579] J. Wijnholds,et al. The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. , 1999, Cancer research.
[580] H. Nakauchi,et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype , 2001, Nature Medicine.
[581] Joanne Wang,et al. Molecular Determinants of Substrate Selectivity of a Novel Organic Cation Transporter (PMAT) in the SLC29 Family* , 2007, Journal of Biological Chemistry.
[582] P. Borst,et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[583] D. Keppler,et al. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. , 1996, Cancer research.
[584] Ning Li,et al. Role of liver-enriched transcription factors in the down-regulation of organic anion transporting polypeptide 4 (oatp4; oatplb2; slc21a10) by lipopolysaccharide. , 2004, Molecular pharmacology.
[585] J. Nezu,et al. Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. , 2002, The Journal of pharmacology and experimental therapeutics.
[586] R. Cecchelli,et al. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood–brain barrier , 2007, Journal of neurochemistry.
[587] P. Denéfle,et al. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[588] P. Johnston,et al. The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites , 2005, Molecular Cancer Therapeutics.
[589] M. J. van de Vijver,et al. Expression of the breast cancer resistance protein in breast cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[590] H. Nishimori,et al. A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse. , 1998, Biochemical and biophysical research communications.
[591] D. Adams,et al. Localization of ABCG5 and ABCG8 proteins in human liver, gall bladder and intestine , 2004, BMC gastroenterology.
[592] Y. Kato,et al. PDZK1 Directly Regulates the Function of Organic Cation/Carnitine Transporter OCTN2 , 2005, Molecular Pharmacology.
[593] S. Masuda,et al. Pharmacokinetic significance of luminal multidrug and toxin extrusion 1 in chronic renal failure rats. , 2007, Biochemical pharmacology.
[594] T. Willson,et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[595] J. Gallo,et al. The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice. , 2003, Cancer research.
[596] M. Beaussier,et al. Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[597] Y. Sugiyama,et al. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. , 1997, The American journal of physiology.
[598] R. Neubert,et al. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). , 2005, Biochemical pharmacology.
[599] K. Fukushi,et al. Noninvasive and Quantitative Assessment of the Function of Multidrug Resistance-Associated Protein 1 in the Living Brain , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[600] Conrad C. Huang,et al. Interaction of Methotrexate with Organic-Anion Transporting Polypeptide 1A2 and Its Genetic Variants , 2006, Journal of Pharmacology and Experimental Therapeutics.
[601] G. Burckhardt,et al. Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones. , 2007, American journal of physiology. Renal physiology.
[602] V. Ganapathy,et al. Identity of the Organic Cation Transporter OCT3 as the Extraneuronal Monoamine Transporter (uptake2) and Evidence for the Expression of the Transporter in the Brain* , 1998, The Journal of Biological Chemistry.
[603] Xingguo Cheng,et al. TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE , 2005, Drug Metabolism and Disposition.
[604] P. Glue,et al. Intestinal Absorption of Ribavirin Is Preferentially Mediated by the Na+-Nucleoside Purine (Nl) Transporter , 1998, Pharmaceutical Research.
[605] A. Schinkel,et al. TRANSPORT OF ANTHELMINTIC BENZIMIDAZOLE DRUGS BY BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2) , 2005, Drug Metabolism and Disposition.
[606] J. Wijnholds,et al. Characterization of the MRP4- and MRP5-mediated Transport of Cyclic Nucleotides from Intact Cells* , 2003, The Journal of Biological Chemistry.
[607] W. Haefeli,et al. Localization of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) in Lipid Rafts/Caveolae and Modulation of Its Activity by Cholesterol in Vitro , 2007, Journal of Pharmacology and Experimental Therapeutics.
[608] P. McNamara,et al. Active Transport of Nitrofurantoin into Human Milk , 2001, Pharmacotherapy.
[609] D. Rosskopf,et al. Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1 , 2008, Pharmacogenetics and genomics.
[610] Yoshikatsu Kanai,et al. The Multivalent PDZ Domain-containing Protein PDZK1 Regulates Transport Activity of Renal Urate-Anion Exchanger URAT1 via Its C Terminus* , 2004, Journal of Biological Chemistry.
[611] Sarfaraz Ahmad,et al. Handling of cysteine S-conjugates of methylmercury in MDCK cells expressing human OAT1. , 2005, Kidney international.
[612] D. Butterfield,et al. Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6 mice , 2006, Molecular Cancer Therapeutics.
[613] I. Roninson,et al. Structure and expression of the human MDR (P-glycoprotein) gene family , 1989, Molecular and cellular biology.
[614] M. Breen,et al. pABC11 (Also Known as MOAT-C and MRP5), a Member of the ABC Family of Proteins, Has Anion Transporter Activity but Does Not Confer Multidrug Resistance When Overexpressed in Human Embryonic Kidney 293 Cells* , 1999, The Journal of Biological Chemistry.
[615] S. Masuda,et al. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2. , 2009, Biochemical pharmacology.
[616] V. Ganapathy,et al. β-Lactam Antibiotics as Substrates for OCTN2, an Organic Cation/Carnitine Transporter* , 2000, The Journal of Biological Chemistry.
[617] D. Keppler,et al. Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6* , 2001, The Journal of Biological Chemistry.
[618] Bruno Stieger,et al. Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. , 2009, American journal of physiology. Cell physiology.
[619] J. Fritschy,et al. Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood–brain barrier , 2006, Neuroscience.
[620] Stephen A Baldwin,et al. Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3. , 2009, American journal of physiology. Renal physiology.
[621] Tianxin Yang,et al. Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. , 1999, American journal of physiology. Renal physiology.
[622] T. Hasegawa,et al. Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats. , 2006, Life sciences.
[623] J. Nezu,et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. , 1999, The Journal of pharmacology and experimental therapeutics.
[624] F. Lammert,et al. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene , 2006, Gut.
[625] G. Merino,et al. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. , 2006, Journal of veterinary pharmacology and therapeutics.
[626] B. Vig,et al. Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum. , 2003, Biochemical and biophysical research communications.
[627] D. Schrenk,et al. A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. , 2002, Pharmacogenetics.
[628] M. Karin,et al. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. , 2007, Drug metabolism and disposition: the biological fate of chemicals.
[629] U. Brinkmann,et al. Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. , 2002, Pharmacogenetics.
[630] K. Miyamoto,et al. Loss of wild‐type carrier‐mediated L‐carnitine transport activity in hepatocytes of juvenile visceral steatosis mice , 1999, Hepatology.
[631] Y. Kato,et al. Organic Cation/Carnitine Transporter OCTN2 (Slc22a5) Is Responsible for Carnitine Transport across Apical Membranes of Small Intestinal Epithelial Cells in Mouse , 2006, Molecular Pharmacology.
[632] I. Tamai,et al. Transport of organic cations across the blood-testis barrier. , 2007, Molecular pharmaceutics.
[633] Jan Stankiewicz,et al. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. , 2003, Pharmacogenetics.
[634] D. Keppler,et al. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in dubin‐johnson syndrome , 2000, Hepatology.
[635] C. Klaassen,et al. ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[636] Masaki Kobayashi,et al. Contribution of organic anion transporting polypeptide OATP2B1 to amiodarone accumulation in lung epithelial cells. , 2009, Biochimica et biophysica acta.
[637] P. Meier,et al. Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver , 2001 .
[638] A. Schinkel,et al. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. , 2009, Advanced drug delivery reviews.
[639] K. Siminovitch,et al. SLC22A4 polymorphisms implicated in rheumatoid arthritis and Crohn's disease are not associated with rheumatoid arthritis in a Canadian Caucasian population. , 2005, Arthritis and rheumatism.
[640] H. Endou,et al. Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. , 2002, Journal of the American Society of Nephrology : JASN.
[641] H. Kusuhara,et al. Transcriptional Regulation of Human and Mouse Organic Anion Transporter 1 by Hepatocyte Nuclear Factor 1 α/β , 2008, Journal of Pharmacology and Experimental Therapeutics.
[642] Xingguo Cheng,et al. Regulation of mRNA Expression of Xenobiotic Transporters by the Pregnane X Receptor in Mouse Liver, Kidney, and Intestine , 2006, Drug Metabolism and Disposition.
[643] S. Waxman,et al. Disruption of cAMP and Prostaglandin E2 Transport by Multidrug Resistance Protein 4 Deficiency Alters cAMP-Mediated Signaling and Nociceptive Response , 2007, Molecular Pharmacology.
[644] D. Keppler,et al. The Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic Nucleotides* , 2000, The Journal of Biological Chemistry.
[645] R L Juliano,et al. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.
[646] G. Kruh,et al. © 1999 Cancer Research Campaign Article no. bjoc.1999.0527 MOAT-E (ARA) is a full-length MRP/cMOAT subfamily , 2022 .
[647] L. Varticovski,et al. Mechanisms by which cAMP increases bile acid secretion in rat liver and canalicular membrane vesicles. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[648] P. Meier,et al. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. , 2003, Biochimica et biophysica acta.
[649] R. Kim,et al. Human Organic Anion Transporting Polypeptide-C (SLC21A6) Is a Major Determinant of Rifampin-Mediated Pregnane X Receptor Activation , 2003, Journal of Pharmacology and Experimental Therapeutics.
[650] J. Schellens,et al. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. , 2000, Journal of the National Cancer Institute.
[651] G. Rudenko,et al. N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. , 1993, The Journal of biological chemistry.
[652] G. Koren,et al. Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta. , 2008, Placenta.
[653] N. Longo,et al. Tyrosine Residues Affecting Sodium Stimulation of Carnitine Transport in the OCTN2 Carnitine/Organic Cation Transporter* , 2004, Journal of Biological Chemistry.
[654] T. Abe,et al. Molecular characterization of human and rat organic anion transporter OATP-D. , 2003, American journal of physiology. Renal physiology.
[655] D. Keppler,et al. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. , 1996, The Biochemical journal.
[656] N. Niikawa,et al. A strong association between human earwax-type and apocrine colostrum secretion from the mammary gland , 2007, Human Genetics.
[657] P. Dawson,et al. Identification of a Mutation in the Ileal Sodium-dependent Bile Acid Transporter Gene That Abolishes Transport Activity (*) , 1995, The Journal of Biological Chemistry.
[658] Xin He,et al. Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. , 2005, Journal of the American Society of Nephrology : JASN.
[659] K. Giacomini,et al. Cloning and functional expression of a human liver organic cation transporter. , 1997, Molecular pharmacology.
[660] Xingguo Cheng,et al. Regulation of hepatic bile acid transporters Ntcp and Bsep expression. , 2007, Biochemical pharmacology.
[661] J. Bene,et al. Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease. , 2006, World journal of gastroenterology.
[662] G. Peters,et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[663] C. Klaassen,et al. Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[664] Mei-Hwei Chang,et al. Developmental expression of canalicular transporter genes in human liver. , 2004, Journal of hepatology.
[665] B. Sarkadi,et al. Subcellular localization and N-glycosylation of human ABCC6, expressed in MDCKII cells. , 2003, Biochemical and biophysical research communications.
[666] Yuichi Sugiyama,et al. Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. , 2003, Biochemical and biophysical research communications.
[667] M. L. Calonge,et al. Ontogeny of Na+/l-carnitine transporter and of γ-trimethylaminobutyraldehyde dehydrogenase and γ-butyrobetaine hydroxylase genes expression in rat kidney , 2009, Mechanisms of Ageing and Development.
[668] T. Mizuno,et al. Targeted Disruption of the Multidrug and Toxin Extrusion 1 (Mate1) Gene in Mice Reduces Renal Secretion of Metformin , 2009, Molecular Pharmacology.
[669] Y. Kato,et al. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart. , 2008, Drug metabolism and pharmacokinetics.
[670] D. Goldstein,et al. ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. , 2006, Human molecular genetics.
[671] Conrad C. Huang,et al. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. , 2002, Pharmacogenetics.
[672] H. Saito,et al. Molecular cloning and tissue distribution of rat peptide transporter PEPT2. , 1996, Biochimica et biophysica acta.
[673] T. Hirano,et al. Cyclosporin A, but Not Tacrolimus, Inhibits the Biliary Excretion of Mycophenolic Acid Glucuronide Possibly Mediated by Multidrug Resistance-Associated Protein 2 in Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.
[674] F. Lang,et al. Cloning and characterization of two human polyspecific organic cation transporters. , 1997, DNA and cell biology.
[675] A. Engel,et al. Primary systemic carnitine deficiency , 1981, Neurology.
[676] D. Keppler,et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C–dependent mechanisms in cholestatic rat liver , 2001, Hepatology.
[677] Zhe-Sheng Chen,et al. Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B. , 2009, Cancer research.
[678] D. Moore,et al. Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[679] Kuniharu Nakai,et al. Phospholipid Alterations in Hepatocyte Membranes and Transporter Protein Changes in Cholestatic Rat Model , 2001, Digestive Diseases and Sciences.
[680] J. C. Jones,et al. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. , 1998, Journal of immunology.
[681] M. Hediger,et al. Distribution of peptide transporter PEPT2 mRNA in the rat nervous system , 1999, Anatomy and Embryology.
[682] R. Kim,et al. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. , 2006, Gastroenterology.
[683] J. Wijnholds,et al. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. , 2006, Journal of hepatology.
[684] M. Barrand,et al. Localisation of breast cancer resistance protein in microvessel endothelium of human brain , 2002, Neuroreport.
[685] I. Paulsen,et al. The multidrug efflux protein NorM is a prototype of a new family of transporters , 1999, Molecular microbiology.
[686] Donald W. Miller,et al. Plasma Membrane Localization of Multidrug Resistance-Associated Protein Homologs in Brain Capillary Endothelial Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.
[687] A. Klein-Szanto,et al. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. , 2000, Journal of the National Cancer Institute.
[688] C. Ackerley,et al. OCTN3 is a mammalian peroxisomal membrane carnitine transporter. , 2005, Biochemical and biophysical research communications.
[689] J. Petrick,et al. TISSUE DISTRIBUTION AND ONTOGENY OF ORGANIC CATION TRANSPORTERS IN MICE , 2006, Drug Metabolism and Disposition.
[690] Richard J. Thompson,et al. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency , 2006, Hepatology.
[691] Conrad C. Huang,et al. Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4). , 2007, Pharmacogenetics and genomics.
[692] Bhandari,et al. Fumonisin toxicity in a transgenic mouse model lacking the mdr1a/1b P-glycoprotein genes. , 2000, Environmental toxicology and pharmacology.
[693] A. Klein-Szanto,et al. Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage. , 2007, Cancer research.
[694] M. Hayden,et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. , 2005, The Journal of clinical investigation.
[695] K. Verbeke,et al. Multidrug Resistance Protein 2 Genetic Polymorphisms Influence Mycophenolic Acid Exposure in Renal Allograft Recipients , 2006, Transplantation.
[696] A. Hofmann,et al. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. , 1997, Gastroenterology.
[697] J. Nezu,et al. Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2* , 1998, The Journal of Biological Chemistry.
[698] F. Suchy,et al. Multiple Factors Regulate the Rat Liver Basolateral Sodium-dependent Bile Acid Cotransporter Gene Promoter* , 1996, The Journal of Biological Chemistry.
[699] A. Groen,et al. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. , 1995, The Journal of clinical investigation.
[700] R. Kim,et al. Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. , 2008, Cancer research.
[701] M. Romero,et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter , 1994, Nature.
[702] S. Choudhuri,et al. Cloning, expression, and ontogeny of mouse organic anion-transporting polypeptide-5, a kidney-specific organic anion transporter. , 2001, Biochemical and biophysical research communications.
[703] Y. Kato,et al. PDZK1 Regulates Two Intestinal Solute Carriers (Slc15a1 and Slc22a5) in Mice , 2008, Drug Metabolism and Disposition.
[704] H. Kusuhara,et al. P-glycoprotein Restricts the Penetration of Oseltamivir Across the Blood-Brain Barrier , 2008, Drug Metabolism and Disposition.
[705] P. Meier,et al. Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. , 1996, The Biochemical journal.
[706] M. L. Calonge,et al. OCTN3: A Na+‐independent L‐carnitine transporter in enterocytes basolateral membrane , 2005, Journal of cellular physiology.
[707] J. Nezu,et al. Molecular and Functional Characterization of Organic Cation/Carnitine Transporter Family in Mice* , 2000, The Journal of Biological Chemistry.
[708] K. Amsler,et al. Regulation of mOAT-mediated Organic Anion Transport by Okadaic Acid and Protein Kinase C in LLC-PK1 Cells* , 2000, The Journal of Biological Chemistry.
[709] D. Piwnica-Worms,et al. Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains. , 2000, Biochemistry.
[710] S. Yao,et al. Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. , 1994, The Journal of biological chemistry.
[711] R. Miller,et al. Altered development of intestinal intraepithelial lymphocytes in P-glycoprotein-deficient mice. , 2000, Developmental and comparative immunology.
[712] V. Ling,et al. Identification of a sister gene to P-glycoprotein. , 1995, Cancer research.
[713] T. Matsuishi,et al. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. , 1999, Human molecular genetics.
[714] J. Boyer,et al. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. , 1998, The Journal of clinical investigation.
[715] C. Funk,et al. Substrate-Dependent Drug-Drug Interactions between Gemfibrozil, Fluvastatin and Other Organic Anion-Transporting Peptide (OATP) Substrates on OATP1B1, OATP2B1, and OATP1B3 , 2007, Drug Metabolism and Disposition.
[716] D. Keppler,et al. Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. , 2001, Gastroenterology.
[717] I. Tamai,et al. Identification of influx transporter for the quinolone antibacterial agent levofloxacin. , 2007, Molecular pharmaceutics.
[718] Peijin Zhang,et al. Role of Glycosylation in Trafficking of Mrp2 in Sandwich-Cultured Rat Hepatocytes , 2005, Molecular Pharmacology.
[719] J. Testa,et al. Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. , 1998, Journal of the National Cancer Institute.
[720] L. M. Hodges,et al. Substrate-Dependent Effects of Human ABCB1 Coding Polymorphisms , 2008, Journal of Pharmacology and Experimental Therapeutics.
[721] K. Boekelheide,et al. XENOBIOTIC AND ENDOBIOTIC TRANSPORTER MRNA EXPRESSION IN THE BLOOD-TESTIS BARRIER , 2005, Drug Metabolism and Disposition.
[722] H. Kusuhara,et al. Investigation of Efflux Transport of Dehydroepiandrosterone Sulfate and Mitoxantrone at the Mouse Blood-Brain Barrier: A Minor Role of Breast Cancer Resistance Protein , 2005, Journal of Pharmacology and Experimental Therapeutics.
[723] C. R. Crawford,et al. Cloning, genomic organization and chromosomal localization of the gene encoding the murine sodium-dependent, purine-selective, concentrative nucleoside transporter (CNT2). , 2000, Gene.
[724] C. Webster,et al. Protein kinase Cδ mediates cyclic adenosine monophosphate–stimulated translocation of sodium taurocholate cotransporting polypeptide and multidrug resistant associated protein 2 in rat hepatocytes , 2007, Hepatology.
[725] K. Motojima,et al. PPARalpha agonists positively and negatively regulate the expression of several nutrient/drug transporters in mouse small intestine. , 2007, Biological & pharmaceutical bulletin.
[726] A. Calcagno,et al. Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor , 2006, Molecular Cancer Therapeutics.
[727] K. Faber,et al. Multidrug resistance–associated proteins are crucial for the viability of activated rat hepatic stellate cells , 2008, Hepatology.
[728] J. Boyer,et al. Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[729] D. Keppler,et al. Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[730] A. Schinkel,et al. Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations , 2003, Molecular and Cellular Biology.
[731] P. Meier,et al. Expression cloning of a rat liver Na(+)-independent organic anion transporter. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[732] N. Ballatori,et al. The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway , 2009, Proceedings of the National Academy of Sciences.
[733] Yuichi Sugiyama,et al. Evaluation of the Role of Breast Cancer Resistance Protein (BCRP/ABCG2) and Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in The Urinary Excretion of Sulfate and Glucuronide Metabolites of Edaravone (MCI-186; 3-Methyl-1-phenyl-2-pyrazolin-5-one) , 2007, Drug Metabolism and Disposition.
[734] H. Takikawa,et al. Effects of lipopolysaccharide on the biliary excretion of bile acids and organic anions in rats , 2003, Journal of gastroenterology and hepatology.
[735] M. Takano,et al. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. , 1996, Biochemical and biophysical research communications.
[736] M. Kool,et al. Tissue Distribution and Induction of Human Multidrug Resistant Protein 3 , 2002, Laboratory Investigation.
[737] R. Kim,et al. Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2). , 2008, Drug metabolism reviews.
[738] W. Wahli,et al. Fatty acids, eicosanoids, and hypolipidemic agents regulate gene expression through direct binding to peroxisome proliferator-activated receptors. , 1999, Advances in experimental medicine and biology.
[739] P. Giral,et al. Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy. , 2008, Pharmacogenomics.
[740] G. Decorti,et al. Physiological regulation of P‐glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny , 2003, Development, growth & differentiation.
[741] M. Kuwano,et al. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. , 2002, Cancer research.
[742] J. Wijnholds,et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[743] R. Stocco,et al. Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport , 2005, Xenobiotica; the fate of foreign compounds in biological systems.
[744] Jonathan C. Cohen,et al. ABCG5 and ABCG8 Are Obligate Heterodimers for Protein Trafficking and Biliary Cholesterol Excretion* , 2003, Journal of Biological Chemistry.
[745] J. Mackey,et al. Differential Transport of Cytosine-Containing Nucleosides by Recombinant Human Concentrative Nucleoside Transporter Protein hCNT1 , 2000, Nucleosides, nucleotides & nucleic acids.
[746] G. Amidon,et al. Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein , 2001, AAPS PharmSci.
[747] C. Beglinger,et al. MAPPING OF MULTIDRUG RESISTANCE GENE 1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN ISOFORM 1 TO 5 mRNA EXPRESSION ALONG THE HUMAN INTESTINAL TRACT , 2005, Drug Metabolism and Disposition.
[748] V. Ling,et al. Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P‐glycoprotein , 2003, Hepatology.
[749] E. Eicher,et al. Stimulation of growth in the little mouse. , 1976, The Journal of endocrinology.
[750] Y. Kanai,et al. Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. , 2000, The Journal of pharmacology and experimental therapeutics.
[751] G. Merino,et al. Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: modulation by isoflavones. , 2009, Journal of veterinary pharmacology and therapeutics.
[752] P. Duan,et al. Regulation of human organic anion transporter 4 by parathyroid hormone-related protein and protein kinase A. , 2012, International journal of biochemistry and molecular biology.
[753] D. Keppler,et al. Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. , 1996, European journal of biochemistry.
[754] C. Gabel,et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[755] L. Bain,et al. The multidrug resistance-associated protein 1 transports methoxychlor and protects the seminiferous epithelium from injury. , 2003, Toxicology letters.
[756] J. Boyer,et al. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II. , 2002, The Journal of clinical investigation.
[757] Guoyu Pan,et al. Abcg2/Bcrp1 Mediates the Polarized Transport of Antiretroviral Nucleosides Abacavir and Zidovudine , 2007, Drug Metabolism and Disposition.
[758] D. Oh,et al. Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers , 2005, Clinical pharmacology and therapeutics.
[759] S. Grimm,et al. ATP-DEPENDENT TRANSPORT OF ROSUVASTATIN IN MEMBRANE VESICLES EXPRESSING BREAST CANCER RESISTANCE PROTEIN , 2006, Drug Metabolism and Disposition.
[760] Y. Sugiyama,et al. Functional Analysis of SNPs Variants of BCRP/ABCG2 , 2004, Pharmaceutical Research.
[761] D. Keppler,et al. ATP-Dependent Transport of Leukotrienes B4 and C4 by the Multidrug Resistance Protein ABCC4 (MRP4) , 2008, Journal of Pharmacology and Experimental Therapeutics.
[762] J. van Lunzen,et al. Relevance of the Organic Cation Transporters 1 and 2 for Antiretroviral Drug Therapy in Human Immunodeficiency Virus Infection , 2008, Drug Metabolism and Disposition.
[763] H. Kusuhara,et al. Regulation of the Expression of Human Organic Anion Transporter 3 by Hepatocyte Nuclear Factor 1α/β and DNA Methylation , 2006, Molecular Pharmacology.
[764] D. Mangelsdorf,et al. Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. , 2002, Gastroenterology.
[765] R. Kerwin,et al. Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters , 2003, British journal of pharmacology.
[766] C. Klaassen,et al. Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[767] D. Keppler,et al. Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome. , 1999, Gastroenterology.
[768] Joe Palandra,et al. Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe , 2008, Pharmacogenetics and genomics.
[769] J. Boyer,et al. Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. , 1996, Gastroenterology.
[770] T. Eschenhagen,et al. High‐dose methotrexate in pediatric acute lymphoblastic leukemia: Impact of ABCC2 polymorphisms on plasma concentrations , 2006, Clinical pharmacology and therapeutics.
[771] D D Breimer,et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. , 2000, The Journal of clinical investigation.
[772] J. Moseley,et al. Myosin II Regulatory Light Chain Is Required for Trafficking of Bile Salt Export Protein to the Apical Membrane in Madin-Darby Canine Kidney Cells* , 2005, Journal of Biological Chemistry.
[773] J. Nezu,et al. OCTN2-mediated transport of carnitine in isolated Sertoli cells. , 2005, Reproduction.
[774] R. Keep,et al. Mechanisms of Cefadroxil Uptake in the Choroid Plexus: Studies in Wild-Type and PEPT2 Knockout Mice , 2004, Journal of Pharmacology and Experimental Therapeutics.
[775] Yi Wang,et al. Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin , 2008, Drug Metabolism and Disposition.
[776] D. Keppler,et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis , 2005, Hepatology.
[777] Conrad C. Huang,et al. The Human Multidrug Resistance Protein 4 (MRP4, ABCC4): Functional Analysis of a Highly Polymorphic Gene , 2008, Journal of Pharmacology and Experimental Therapeutics.
[778] Y. Kato,et al. Screening of the Interaction Between Xenobiotic Transporters and PDZ Proteins , 2004, Pharmaceutical Research.
[779] C. Grimm,et al. Localization of organic anion transport protein 2 in the apical region of rat retinal pigment epithelium. , 2002, Investigative ophthalmology & visual science.
[780] Xin Wang,et al. Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. , 2003, Molecular pharmacology.
[781] Paul T Tarr,et al. Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.
[782] Z. Bacso,et al. Raft and cytoskeleton associations of an ABC transporter: P‐glycoprotein , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[783] I. Roots,et al. In-vitro transport characteristics discriminate wild-type ABCB1 (MDR1) from ALA893SER and ALA893THR polymorphisms , 2006, Pharmacogenetics and genomics.
[784] T. Ishikawa,et al. Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. , 2007, Journal of experimental therapeutics & oncology.
[785] Martin F. Fromm,et al. The Influence of Macrolide Antibiotics on the Uptake of Organic Anions and Drugs Mediated by OATP1B1 and OATP1B3 , 2007, Drug Metabolism and Disposition.
[786] T. Langmann,et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice , 2000, Nature Genetics.
[787] D. Thakker,et al. Differential Substrate and Inhibitory Activities of Ranitidine and Famotidine toward Human Organic Cation Transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3) , 2005, Journal of Pharmacology and Experimental Therapeutics.
[788] D. Moore,et al. Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration , 2006, Science.
[789] P. Meier,et al. Functional characterization of the mouse organic-anion-transporting polypeptide 2. , 2002, Biochimica et biophysica acta.
[790] L. Bain,et al. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. , 1999, Cancer research.
[791] M. J. van de Vijver,et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. , 2001, Cancer research.
[792] R. Ringseis,et al. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. , 2007, Pharmacological research.
[793] K. Roberg,et al. Molecular cloning and characterization of a novel liver-specific transport protein. , 1994, Journal of cell science.
[794] A. Wolkoff,et al. Characterization of the mechanisms involved in the gender differences in hepatic taurocholate uptake. , 1999, The American journal of physiology.
[795] D. Eastmond,et al. Postulated Carbon Tetrachloride Mode of Action: A Review , 2007, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.
[796] H. Kusuhara,et al. The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules. , 2004, Journal of the American Society of Nephrology : JASN.
[797] K. Brouwer,et al. Evaluation of the Role of Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 in Hepatic Basolateral Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Abcc3–/– and Abcc4–/– Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.
[798] B. Staels,et al. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. , 2003, The Biochemical journal.
[799] Y. Moriyama,et al. Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[800] Xingguo Cheng,et al. Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice. , 2008, Life sciences.
[801] M. Iyo,et al. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. , 2006, Alcoholism, clinical and experimental research.
[802] D. Keppler,et al. A Naturally Occurring Mutation in the SLC21A6Gene Causing Impaired Membrane Localization of the Hepatocyte Uptake Transporter* , 2002, The Journal of Biological Chemistry.
[803] A. Enomoto,et al. Interactions of human organic anion as well as cation transporters with indoxyl sulfate. , 2003, European journal of pharmacology.
[804] Vincenzo,et al. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. , 1998, Cancer research.
[805] J. Beijnen,et al. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice. , 1996, Journal of the National Cancer Institute.
[806] G. Reid,et al. Cloning of a Human Renal p–Aminohippurate Transporter, hROAT1 , 2008, Kidney and Blood Pressure Research.
[807] V. Vallon,et al. Decreased Renal Organic Anion Secretion and Plasma Accumulation of Endogenous Organic Anions in OAT1 Knock-out Mice* , 2006, Journal of Biological Chemistry.
[808] C. Klaassen,et al. Application of multivariate statistical procedures to identify transcription factors that correlate with MRP2, 3, and 4 mRNA in adult human livers , 2009, Xenobiotica; the fate of foreign compounds in biological systems.
[809] T. Willson,et al. Peroxisome proliferator activated receptor agonists. , 1997, EXS.
[810] S. Vavricka,et al. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[811] Jie Liu,et al. Limited protective role of V-PYRRO/NO against cholestasis produced by alpha-naphthylisothiocyanate in mice. , 2005, Biochemical pharmacology.
[812] D. Keppler,et al. Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide* , 2000, The Journal of Biological Chemistry.
[813] C. Cass,et al. Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain. , 1999, Brain research. Molecular brain research.
[814] A Felipe,et al. Developmental regulation of the concentrative nucleoside transporters CNT1 and CNT2 in rat liver. , 2001, Journal of hepatology.
[815] U. Broeckel,et al. Contribution of OCTN Variants Within the IBD5 Locus to Pediatric Onset Crohn's Disease , 2006, The American Journal of Gastroenterology.
[816] Wei Li,et al. The 5′-Untranslated Region of Multidrug Resistance Associated Protein 2 (MRP2; ABCC2) Regulates Downstream Open Reading Frame Expression through Translational Regulation , 2010, Molecular Pharmacology.
[817] J. Kingdom,et al. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. , 2006, Placenta.
[818] I. Tamai,et al. Predominant Contribution of Rat Organic Anion Transporting Polypeptide-2 (Oatp2) to Hepatic Uptake of β-Lactam Antibiotics , 2008, Pharmaceutical Research.
[819] J. Schellens,et al. Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[820] T. Abe,et al. Identification and characterization of novel rat and human gonad-specific organic anion transporters. , 2003, Molecular endocrinology.
[821] Y. Sawada,et al. CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B , 2005, Drug Metabolism and Disposition.
[822] Yuichi Sugiyama,et al. Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans , 2008, Clinical pharmacology and therapeutics.
[823] Markus Grube,et al. Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation. , 2005, The American journal of pathology.
[824] J. Mackey,et al. Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. , 1998, Molecular membrane biology.
[825] Jie Liu,et al. Multidrug-resistance mdr1a/1b double knockout mice are more sensitive than wild type mice to acute arsenic toxicity, with higher arsenic accumulation in tissues. , 2002, Toxicology.
[826] I. Schoots,et al. Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats. , 2001, Molecular pharmacology.
[827] K. Allen,et al. Defective localization of the Wilson disease protein (ATP7B) in the mammary gland of the toxic milk mouse and the effects of copper supplementation. , 2000, The Biochemical journal.
[828] T. Litman,et al. Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. , 2006, Cancer letters.
[829] P. Meier,et al. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. , 1994, The Journal of clinical investigation.
[830] M. Vore,et al. Expression and localization of multidrug resistant protein mrp2 in rat small intestine. , 2000, The Journal of pharmacology and experimental therapeutics.
[831] U. Brinkmann,et al. Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart. , 2003, The American journal of pathology.
[832] D. Keppler,et al. Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8). , 2004, Pharmacogenetics.
[833] T. Uchiumi,et al. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2) , 1999, FEBS letters.
[834] T. Komatsu,et al. Functional characterization of testis-specific rodent multidrug and toxic compound extrusion 2, a class III MATE-type polyspecific H+/organic cation exporter. , 2007, American journal of physiology. Cell physiology.
[835] Carol E. Cass,et al. Functional Characterization of Novel Human and Mouse Equilibrative Nucleoside Transporters (hENT3 and mENT3) Located in Intracellular Membranes* , 2005, Journal of Biological Chemistry.
[836] A. Pandya,et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. , 2001, American journal of human genetics.
[837] D. Bell,et al. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. , 1998, Cancer research.
[838] F. Gonzalez,et al. Regulation of drug transporters by the farnesoid X receptor in mice. , 2004, Molecular pharmaceutics.
[839] H. Koepsell,et al. Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. , 2005, American journal of respiratory cell and molecular biology.
[840] H. Kusuhara,et al. Contribution of Organic Anion Transporter 3 (Slc22a8) to the Elimination of p-Aminohippuric Acid and Benzylpenicillin across the Blood-Brain Barrier , 2003, Journal of Pharmacology and Experimental Therapeutics.
[841] M. Haberl,et al. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis. , 2005, Journal of hepatology.
[842] Masayuki Yamamoto,et al. Oxidative and electrophilic stress induces multidrug resistance–associated protein transporters via the nuclear factor‐E2–related factor‐2 transcriptional pathway , 2007, Hepatology.
[843] F. Russel,et al. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. , 2002, Journal of the American Society of Nephrology : JASN.
[844] R. Messing,et al. The type 1 equilibrative nucleoside transporter regulates anxiety‐like behavior in mice , 2007, Genes, brain, and behavior.
[845] I. Rubio-Aliaga,et al. Cloning and characterization of the gene encoding the mouse peptide transporter PEPT2. , 2000, Biochemical and biophysical research communications.
[846] J. Wijnholds,et al. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. , 2003, Molecular pharmacology.
[847] A. Jongsma,et al. Tissue distribution of the human MDR3 P-glycoprotein. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[848] H. Kroemer,et al. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex , 2007, The Pharmacogenomics Journal.
[849] I. Song,et al. Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake , 2012, Biopharmaceutics & drug disposition.
[850] K. Zatloukal,et al. Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[851] F. Brosius,et al. Developmental Expression of PEPT1 and PEPT2 in Rat Small Intestine, Colon, and Kidney , 2001, Pediatric Research.
[852] C. Klaassen,et al. Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance associated protein 2 (Mrp2). , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[853] R. Green,et al. Molecular cloning and characterization of the murine bile salt export pump. , 2000, Gene.
[854] J. Camakaris,et al. Distinct Functional Roles for the Menkes and Wilson Copper Translocating P-type ATPases in Human Placental Cells , 2007, Cellular Physiology and Biochemistry.
[855] Daxi Sun,et al. Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution. , 2007, Cancer research.
[856] Yuichi Sugiyama,et al. Inhibition of Bile Acid Transport across Na+/Taurocholate Cotransporting Polypeptide (SLC10A1) and Bile Salt Export Pump (ABCB 11)-Coexpressing LLC-PK1 Cells by Cholestasis-Inducing Drugs , 2006, Drug Metabolism and Disposition.
[857] A. Mahfoudi,et al. Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR) , 1993, Biology of the cell.
[858] C. Meisel,et al. Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn’s disease , 2007, European Journal of Clinical Pharmacology.
[859] C. Paulusma,et al. Activity of the Bile Salt Export Pump (ABCB11) Is Critically Dependent on Canalicular Membrane Cholesterol Content , 2009, Journal of Biological Chemistry.
[860] Masayuki Yamamoto,et al. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[861] Hiroshi Suzuki,et al. Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)* , 1999, The Journal of Biological Chemistry.
[862] S. Vavricka,et al. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-α and -β genes , 2006 .
[863] C. Cass,et al. Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells. , 1996, The Biochemical journal.
[864] Amy G. Aslamkhan,et al. Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells. , 2003, Molecular pharmacology.
[865] Conrad C. Huang,et al. Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1) , 2005, Pharmacogenetics and genomics.
[866] P. Dawson,et al. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). , 1997, The Journal of clinical investigation.
[867] K. Nakao,et al. Kidney‐specific expression of a novel mouse organic cation transporter‐like protein , 1997, FEBS letters.
[868] Y. Sawada,et al. EFFECTS OF HERBAL EXTRACTS ON THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B , 2006, Drug Metabolism And Disposition.
[869] H. Kusuhara,et al. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. , 2003, Molecular pharmacology.
[870] Ulrich Hoffmann,et al. Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition , 2006, Expert opinion on drug metabolism & toxicology.
[871] E. Holtzman,et al. Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). , 1999, Biochemical and biophysical research communications.
[872] Jürgen Roth,et al. ABC‐transporters are localized in caveolin‐1‐positive and reggie‐1‐negative and reggie‐2‐negative microdomains of the canalicular membrane in rat hepatocytes , 2009, Hepatology.
[873] Y. Kanai,et al. The PDZ domain protein PDZK1 interacts with human peptide transporter PEPT2 and enhances its transport activity. , 2006, Kidney international.
[874] T. Suzuki,et al. Expression of organic anion transporting polypeptide E (OATP-E) in human placenta. , 2003, Placenta.
[875] Robert W. Robey,et al. Breast Cancer Resistance Protein , 2006 .
[876] D. Keppler,et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. , 1997, Gastroenterology.
[877] G. Kruh,et al. Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice , 2007, Cancer and Metastasis Reviews.
[878] S. Bates,et al. Single nucleotide polymorphisms modify the transporter activity of ABCG2 , 2005, Cancer Chemotherapy and Pharmacology.
[879] Y. Kanai,et al. Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter* , 1997, The Journal of Biological Chemistry.
[880] G. Burckhardt,et al. Structure of renal organic anion and cation transporters. , 2000, American journal of physiology. Renal physiology.
[881] F. Suchy,et al. cAMP increases liver Na+-taurocholate cotransport by translocating transporter to plasma membranes. , 1997, American journal of physiology. Gastrointestinal and liver physiology.
[882] S. Nakken,et al. ABCB4 sequence variations in young adults with cholesterol gallstone disease , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[883] Jonathan C. Cohen,et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[884] M. Kool,et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin‐Johnson syndrome , 1997, Hepatology.
[885] M. Tomi,et al. Gene expression profiles of ATP-binding cassette transporter A and C subfamilies in mouse retinal vascular endothelial cells. , 2008, Microvascular research.
[886] D. Häussinger,et al. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. , 2006, Gastroenterology.
[887] Katrin Wlcek,et al. Altered expression of organic anion transporter polypeptide (OATP) genes in human breast carcinoma , 2008, Cancer biology & therapy.
[888] K. Faber,et al. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease , 2006, Scandinavian journal of gastroenterology.
[889] T. Gilliam,et al. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. , 1994, Human molecular genetics.
[890] Teruhiko Yoshida,et al. Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population. , 2008, Drug metabolism and pharmacokinetics.
[891] J. Nezu,et al. Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human , 2004, Journal of Pharmacology and Experimental Therapeutics.
[892] J. Megyesi,et al. Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney. , 1997, Nephron.
[893] D. Barlow,et al. The Lxl gene maps to mouse Chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters , 1996, Mammalian Genome.
[894] Wooin Lee,et al. A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression. , 2007, Molecular endocrinology.
[895] J. Unadkat,et al. Breast Cancer Resistance Protein 1 Limits Fetal Distribution of Nitrofurantoin in the Pregnant Mouse , 2007, Drug Metabolism and Disposition.
[896] C. Klaassen,et al. Kupffer Cell-Mediated Downregulation of Hepatic Transporter Expression in Rat Hepatic Ischemia-Reperfusion , 2006, Transplantation.
[897] W. Wahli,et al. Regional variations in ABC transporter expression along the mouse intestinal tract. , 2004, Physiological genomics.
[898] M. Zhou,et al. Subcellular localization of transporters along the rat blood–brain barrier and blood–cerebral-spinal fluid barrier by in vivo biotinylation , 2008, Neuroscience.
[899] F. Baas,et al. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[900] Y. Teo,et al. Effect of MDR1 haplotype on risk of Parkinson disease. , 2005, Archives of neurology.
[901] S. O. Mueller,et al. Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. , 2009, Toxicology and applied pharmacology.
[902] S. Adibi,et al. Characterization of an oligopeptide transporter in renal lysosomes. , 2000, Biochimica et biophysica acta.
[903] C. Andres,et al. ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy , 2009, Journal of Medical Genetics.
[904] M. Kasuga,et al. MDR1 Genotype-Related Duodenal Absorption Rate of Digoxin in Healthy Japanese Subjects , 2003, Pharmaceutical Research.
[905] T. Litman,et al. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2 , 2005, Journal of Cell Science.
[906] R. Keep,et al. Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. , 2004, Molecular pharmaceutics.
[907] C. Ackerley,et al. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[908] P. Meier,et al. In situ localization of the hepatocytic Na+/Taurocholate cotransporting polypeptide in rat liver. , 1994, Gastroenterology.
[909] H. Takane,et al. Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin , 2006, Journal of Human Genetics.
[910] V. Ganapathy,et al. Cloning and Functional Characterization of a Potential-sensitive, Polyspecific Organic Cation Transporter (OCT3) Most Abundantly Expressed in Placenta* , 1998, The Journal of Biological Chemistry.
[911] N. Ballatori,et al. Identification of Glutathione as a Driving Force and Leukotriene C4 as a Substrate for oatp1, the Hepatic Sinusoidal Organic Solute Transporter* , 1998, The Journal of Biological Chemistry.
[912] M. Chen,et al. Increased sensitivity of , 1998 .
[913] M. Wortham,et al. Expression of Constitutive Androstane Receptor, Hepatic Nuclear Factor 4α, and P450 Oxidoreductase Genes Determines Interindividual Variability in Basal Expression and Activity of a Broad Scope of Xenobiotic Metabolism Genes in the Human Liver , 2007, Drug Metabolism and Disposition.
[914] R. Hegele,et al. ABCC6 gene polymorphism associated with variation in plasma lipoproteins , 2001, Journal of Human Genetics.
[915] S. Nigam,et al. Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice. , 2004, American journal of physiology. Renal physiology.
[916] D. Housman,et al. Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells , 1990, Molecular and cellular biology.
[917] J. Bene,et al. Prevalence of SLC22A4 1672T and SLC22A5 −207C combination defined TC haplotype in Hungarian ulcerative colitis patients , 2007, Pathology & Oncology Research.
[918] P. Honkakoski,et al. Induction of drug metabolism by nuclear receptor CAR: molecular mechanisms and implications for drug research. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[919] G. Amidon,et al. Multiple Efflux Pumps Are Involved in the Transepithelial Transport of Colchicine: Combined Effect of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 Leads to Decreased Intestinal Absorption Throughout the Entire Small Intestine , 2009, Drug Metabolism and Disposition.
[920] S. Glaser,et al. Functional expression of the apical Na+-dependent bile acid transporter in large but not small rat cholangiocytes. , 1997, Gastroenterology.
[921] A. Bonci,et al. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference , 2004, Nature Neuroscience.
[922] C. Cass,et al. Role of Human Nucleoside Transporters in the Cellular Uptake of Two Inhibitors of IMP Dehydrogenase, Tiazofurin and Benzamide Riboside , 2005, Molecular Pharmacology.
[923] P. Meier,et al. Expression and characterization of a functional rat liver Na+ bile acid cotransport system in COS-7 cells. , 1994, The American journal of physiology.
[924] J. Wijnholds,et al. Multidrug Resistance Protein 1 Protects the Oropharyngeal Mucosal Layer and the Testicular Tubules against Drug-induced Damage , 1998, The Journal of experimental medicine.
[925] E. Hudson,et al. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). , 2000, Journal of cell science.
[926] H. Rosing,et al. Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics , 2006, Clinical Cancer Research.
[927] Jaana Rysä,et al. ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. , 2008, Toxicology and applied pharmacology.
[928] J. Lippincott-Schwartz,et al. Intracellular trafficking of bile salt export pump (ABCB11) in polarized hepatic cells: constitutive cycling between the canalicular membrane and rab11-positive endosomes. , 2004, Molecular biology of the cell.
[929] S. Lutsenko. Atp7b-/- mice as a model for studies of Wilson's disease. , 2008, Biochemical Society transactions.
[930] J. Nezu,et al. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. , 2000, Biochemical and biophysical research communications.
[931] Adam L VanWert,et al. Impaired Clearance of Methotrexate in Organic Anion Transporter 3 (Slc22a8) Knockout Mice: A Gender Specific Impact of Reduced Folates , 2008, Pharmaceutical Research.
[932] Xingguo Cheng,et al. Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[933] Y. Sugiyama,et al. Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C). , 2004, Pharmacogenetics.
[934] Y. Sugiyama,et al. Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2. , 2000, Pharmaceutical research.
[935] S. Choudhuri,et al. Induction profile of rat organic anion transporting polypeptide 2 (oatp2) by prototypical drug-metabolizing enzyme inducers that activate gene expression through ligand-activated transcription factor pathways. , 2002, The Journal of pharmacology and experimental therapeutics.
[936] Peter J. Meier,et al. Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties , 2004, Pflügers Archiv.
[937] P. McNamara,et al. Active transport of cimetidine into human milk , 1995, Clinical pharmacology and therapeutics.
[938] G. Peters,et al. Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines. , 1998, British Journal of Cancer.
[939] P. A. Rea,et al. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. , 2001, Cancer research.
[940] H. Takikawa,et al. Effects of Organic Anions and Bile Acid Conjugates on Biliary Excretion of Pravastatin in the Rat , 2004, Pharmaceutical Research.
[941] Yuichi Sugiyama,et al. Involvement of Breast Cancer Resistance Protein (ABCG2) in the Biliary Excretion Mechanism of Fluoroquinolones , 2007, Drug Metabolism and Disposition.
[942] M. Kasuga,et al. Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects. , 2002, Biological & pharmaceutical bulletin.
[943] B. Giros,et al. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain , 2006, Neuropharmacology.
[944] P. Meier,et al. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. , 1999, Gastroenterology.
[945] C. Hawkins,et al. Expression patterns of the organic cation/carnitine transporter family in adult murine brain , 2008, Brain and Development.
[946] Thomas Ludwig,et al. Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. , 2004, Kidney international.
[947] Jeffrey S Moffit,et al. Induction of Hepatic Transporters Multidrug Resistance-Associated Proteins (Mrp) 3 and 4 by Clofibrate Is Regulated by Peroxisome Proliferator-Activated Receptor α , 2006, Journal of Pharmacology and Experimental Therapeutics.
[948] Zhe-Sheng Chen,et al. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). , 2003, Molecular pharmacology.
[949] P. Borst,et al. Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene , 2005, Hepatology.
[950] A. Enomoto,et al. Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. , 2002, The Journal of pharmacology and experimental therapeutics.
[951] Yue Weng,et al. Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.
[952] A. Takeuchi,et al. Decreased function of genetic variants, Pro283Leu and Arg287Gly, in human organic cation transporter hOCT1. , 2003, Drug metabolism and pharmacokinetics.
[953] J. Watchko,et al. ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNS , 2008, Neuropediatrics.
[954] L. Braiterman,et al. NH2-terminal signals in ATP7B Cu-ATPase mediate its Cu-dependent anterograde traffic in polarized hepatic cells. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[955] T. Abe,et al. Distribution of organic anion-transporting polypeptide 2 (oatp2) and oatp3 in the rat retina. , 2002, Investigative ophthalmology & visual science.
[956] E. Burchard,et al. Functional Genetic Diversity in the High-Affinity Carnitine Transporter OCTN2 (SLC22A5) , 2006, Molecular Pharmacology.
[957] K. Inui,et al. Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A). , 2008, Biochemical pharmacology.
[958] S. Nigam,et al. Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. , 2004, Biochemical and biophysical research communications.
[959] E. Babu,et al. Human organic anion transporters mediate the transport of tetracycline. , 2002, Japanese journal of pharmacology.
[960] W. Müller,et al. Cholesterol: Coupling between membrane microenvironment and ABC transporter activity. , 2007, Biochemical and biophysical research communications.
[961] Y. Cheung,et al. Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression. , 2005, British journal of clinical pharmacology.
[962] Y. Sugiyama,et al. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). , 1998, FEBS letters.
[963] P. Wielinga,et al. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). , 2003, The Biochemical journal.
[964] Brian Tomlinson,et al. OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine , 2008, Pharmacogenetics and genomics.
[965] D. Häussinger,et al. Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[966] T. Ishikawa,et al. Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart. , 1986, The Journal of biological chemistry.
[967] A. Hofman,et al. Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus , 2009, The Pharmacogenomics Journal.
[968] Zhe-Sheng Chen,et al. Transport of Bile Acids, Sulfated Steroids, Estradiol 17-β-d-Glucuronide, and Leukotriene C4 by Human Multidrug Resistance Protein 8 (ABCC11) , 2005, Molecular Pharmacology.
[969] Y. Sugiyama,et al. Transport Activity of Human MRP3 Expressed in Sf9 Cells: Comparative Studies with Rat MRP3 , 2004, Pharmaceutical Research.
[970] B. M. Forman,et al. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux , 2001, Nature Medicine.
[971] H. Kusuhara,et al. Human Organic Anion Transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) Transport Edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and Its Sulfate Conjugate , 2007, Drug Metabolism and Disposition.
[972] Michael Böhm,et al. Organic anion transporting polypeptide 2B1 is a high‐affinity transporter for atorvastatin and is expressed in the human heart , 2006, Clinical pharmacology and therapeutics.
[973] J. Hayashi,et al. In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.
[974] C. Klaassen,et al. Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[975] G. Tsujimoto,et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter , 1999, Nature Genetics.
[976] T. Ishikawa,et al. In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs. , 2007, Drug metabolism and pharmacokinetics.
[977] J. Ware,et al. Breast Cancer Resistance Protein (BCRP/ABCG2) is a Major Determinant of Sulfasalazine Absorption and Elimination in the Mouse , 2006, Molecular pharmaceutics.
[978] F. Bredin,et al. Evidence for association of OCTN genes and IBD5 with ulcerative colitis , 2005, Gut.
[979] D. Roden,et al. The Organic Cation Transporter, OCTN1, Expressed in the Human Heart, Potentiates Antagonism of the HERG Potassium Channel , 2009, Journal of cardiovascular pharmacology.
[980] M. Anwer,et al. PKCζ Is Required for Microtubule‐Based Motility of Vesicles Containing the ntcp Transporter , 2006, Traffic.
[981] J. Kigawa,et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. , 2001, The Journal of pharmacology and experimental therapeutics.
[982] K. To,et al. Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells , 2003, Pflügers Archiv.
[983] P. Kaufmann,et al. Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). , 2004, Pharmacogenetics.
[984] Nashville Tennessee,et al. Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2) , 2005, Journal of Biological Chemistry.
[985] S. Choudhuri,et al. Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[986] J. Keelan,et al. Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. , 2007, Placenta.
[987] D. Häussinger,et al. Protein kinase C–dependent distribution of the multidrug resistance protein 2 from the canalicular to the basolateral membrane in human HepG2 cells , 2001, Hepatology.
[988] H. Takanaga,et al. Mouse Reduced in Osteosclerosis Transporter Functions as an Organic Anion Transporter 3 and Is Localized at Abluminal Membrane of Blood-Brain Barrier , 2004, Journal of Pharmacology and Experimental Therapeutics.
[989] D. Umbenhauer,et al. The subpopulation of CF‐1 mice deficient in P‐glycoprotein contains a murine retroviral insertion in the mdr1a gene , 2001, Journal of biochemical and molecular toxicology.
[990] Hiroshi Omote,et al. A human transporter protein that mediates the final excretion step for toxic organic cations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[991] D. Häussinger,et al. Degradation of the sodium taurocholate cotransporting polypeptide (NTCP) by the ubiquitin-proteasome system , 2005, Biological chemistry.
[992] Yuichi Sugiyama,et al. Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide. , 2007, Journal of the American Society of Nephrology : JASN.
[993] R. Hyde,et al. Molecular Identification and Characterization of Novel Human and Mouse Concentrative Na+-Nucleoside Cotransporter Proteins (hCNT3 and mCNT3) Broadly Selective for Purine and Pyrimidine Nucleosides (System cib)* , 2001, The Journal of Biological Chemistry.
[994] D. Häussinger,et al. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. , 1999, Gastroenterology.
[995] Shuzhong Zhang,et al. Organic cation transporters are determinants of oxaliplatin cytotoxicity. , 2006, Cancer research.
[996] K. Hillgren,et al. Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine. , 2008, Molecular pharmaceutics.
[997] C. Klaassen,et al. Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[998] Min Goo Lee,et al. Transporter-mediated bile acid uptake causes Ca2+-dependent cell death in rat pancreatic acinar cells. , 2002, Gastroenterology.
[999] Xingguo Cheng,et al. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. , 2006, Biochemical pharmacology.
[1000] P. McNamara,et al. N-(4-[2-(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine Carboxamide (GF120918) As a Chemical ATP-Binding Cassette Transporter Family G Member 2 (Abcg2) Knockout Model to Study Nitrofurantoin Transfer into Milk , 2008, Drug Metabolism and Disposition.
[1001] F. Sirotnak,et al. Molecular cloning of the murine cMOAT ATPase. , 2000, Biochimica et biophysica acta.
[1002] D. Keppler,et al. Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.
[1003] M. Willingham,et al. Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[1004] T. Fujita,et al. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine. , 2006, Drug metabolism and pharmacokinetics.
[1005] J. Nezu,et al. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. , 1999, The Journal of pharmacology and experimental therapeutics.
[1006] K. Maeda,et al. Bile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, Pravastatin , 2005, Journal of Pharmacology and Experimental Therapeutics.
[1007] C. Ko,et al. Characterization of mouse organic anion transporter 5 as a renal steroid sulfate transporter , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[1008] H. Chen,et al. Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[1009] M. Relling,et al. Pharmacogenomics: translating functional genomics into rational therapeutics. , 1999, Science.
[1010] J. Wijnholds,et al. MRP6 (ABCC6) Detection in Normal Human Tissues and Tumors , 2002, Laboratory Investigation.
[1011] Y. Kato,et al. Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population. , 2004, Journal of pharmaceutical sciences.
[1012] T. Dale,et al. Contribution of the ABC Transporters Bcrp1 and Mdr1a/1b to the Side Population Phenotype in Mammary Gland and Bone Marrow of Mice , 2005, Stem cells.
[1013] J. Boyer,et al. Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis , 2006, Hepatology.
[1014] S. Yao,et al. Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[1015] M. Makishima,et al. Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor* , 2001, The Journal of Biological Chemistry.
[1016] K. Wirtz,et al. The human MDR3 P‐glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice , 1994, FEBS letters.
[1017] R. Kim,et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans , 2001, Clinical pharmacology and therapeutics.
[1018] J. Boyer,et al. The organic anion transport polypeptide 1d1 (Oatp1d1) mediates hepatocellular uptake of phalloidin and microcystin into skate liver. , 2007, Toxicology and applied pharmacology.
[1019] M. Zegers,et al. Mechanisms and functional features of polarized membrane traffic in epithelial and hepatic cells. , 1998, The Biochemical journal.
[1020] G. Mitchell,et al. L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2. , 2004, American journal of physiology. Cell physiology.
[1021] G. Burckhardt,et al. Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. , 2004, American journal of physiology. Renal physiology.
[1022] K. Brouwer,et al. Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[1023] F. Sharom,et al. P‐Glycoprotein is localized in intermediate‐density membrane microdomains distinct from classical lipid rafts and caveolar domains , 2005, The FEBS journal.
[1024] S. Cole,et al. Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1). , 2003, Biochemistry.
[1025] Lieke M van der Velden,et al. ATP8B1 is essential for maintaining normal hearing , 2009, Proceedings of the National Academy of Sciences.
[1026] Anand K. Srivastava,et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption , 2001, Nature Genetics.
[1027] D. Keppler,et al. Expression and immunolocalization of the multidrug resistance proteins, MRP1–MRP6 (ABCC1–ABCC6), in human brain , 2004, Neuroscience.
[1028] C. Cass,et al. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system , 2001, Neuropharmacology.
[1029] K. Giacomini,et al. Functional characterization of a human purine-selective, Na+-dependent nucleoside transporter (hSPNT1) in a mammalian expression system. , 1999, The Journal of pharmacology and experimental therapeutics.
[1030] C. Paulusma,et al. Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice. , 2008, Gastroenterology.
[1031] H. Endou,et al. Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice. , 2002, Molecular pharmacology.
[1032] C. Garrovo,et al. St John's wort modulation and developmental expression of multidrug transporters in the rat , 2006, Phytotherapy research : PTR.
[1033] Y. Sawada,et al. Kinetic Analysis of P-Glycoprotein-Mediated Transport by Using Normal Human Placental Brush-Border Membrane Vesicles , 2004, Pharmaceutical Research.
[1034] L. Varticovski,et al. Phosphoinositide 3-kinase lipid products regulate ATP-dependent transport by sister of P-glycoprotein and multidrug resistance associated protein 2 in bile canalicular membrane vesicles. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[1035] Maristela L Onozato,et al. Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. , 2003, European journal of pharmacology.
[1036] V. Ganapathy,et al. Differential Recognition of β-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2 (*) , 1995, The Journal of Biological Chemistry.
[1037] Fanfan Zhou,et al. Regulation of human organic anion transporter 4 by progesterone and protein kinase C in human placental BeWo cells. , 2007, American journal of physiology. Endocrinology and metabolism.
[1038] P. Kurki. [Cyclosporin treatment]. , 1992, Duodecim; laaketieteellinen aikakauskirja.
[1039] Jing Li,et al. Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients , 2007, Cancer biology & therapy.
[1040] C. Klaassen. Plasma disappearance and biliary excretion of sulfobromophthalein and phenol-3,6-dibromphthalein disulfonate after microsomal enzyme induction. , 1970, Biochemical pharmacology.
[1041] J. Boyer,et al. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. , 2004, Journal of hepatology.
[1042] G. Scheffer,et al. Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[1043] K. Faber,et al. ATP binding cassette transporter gene expression in rat liver progenitor cells , 2003, Gut.
[1044] M. Gottesman,et al. Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. , 2002, Molecular pharmacology.
[1045] H. Koepsell,et al. Regulation of the human organic cation transporter hOCT1 , 2004, Journal of cellular physiology.
[1046] H. Kusuhara,et al. Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 alpha/beta and DNA methylation. , 2007, Molecular pharmacology.
[1047] Xingguo Cheng,et al. Expression and regulation of the sterol half-transporter genes ABCG5 and ABCG8 in rats. , 2004, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.
[1048] G. Hooiveld,et al. Upregulation of the multidrug resistance genes mrp1 and mdr1b and downregulation of the organic anion transporter mrp2 and bile salt transporter spgp in endotoxemic rat liver , 1998 .
[1049] H. Koepsell,et al. Calmodulin-associated post-translational regulation of rat organic cation transporter 2 in the kidney is gender dependent , 2009, Cellular and Molecular Life Sciences.
[1050] P. Meier,et al. Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. , 1999, Gastroenterology.
[1051] U. Hofmann,et al. DISPOSITION OF ORAL AND INTRAVENOUS PRAVASTATIN IN MRP2-DEFICIENT TR– RATS , 2005, Drug Metabolism and Disposition.
[1052] W. Duan,et al. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. , 2008, Current medicinal chemistry.
[1053] P. Bosma,et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[1054] Y. Kato,et al. Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2. , 2006, Drug metabolism and pharmacokinetics.
[1055] Y. Kanai,et al. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver , 1998, FEBS letters.
[1056] U. Hofmann,et al. MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. , 2002, British journal of clinical pharmacology.
[1057] D. Beier,et al. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. , 1996, Gastroenterology.
[1058] Y. Sugiyama,et al. Biliary Excretion of 17β-Estradiol 17β-d-Glucuronide Is Predominantly Mediated by cMOAT/MRP2 , 2000, Pharmaceutical Research.
[1059] E. Mayatepek,et al. Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency , 2000, Human mutation.
[1060] T. Schmid,et al. Molecular cloning and functional characterization of the mouse organic-anion-transporting polypeptide 1 (Oatp1) and mapping of the gene to chromosome X. , 2000, The Biochemical journal.
[1061] J. Turner,et al. Modulation of ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: association with lipid rafts. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[1062] J. Nezu,et al. Involvement of Human Organic Anion Transporting Polypeptide OATP-B (SLC21A9) in pH-Dependent Transport across Intestinal Apical Membrane , 2003, Journal of Pharmacology and Experimental Therapeutics.
[1063] C. Shim,et al. Multiple alterations of canalicular membrane transport activities in rats with CCl(4)-induced hepatic injury. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[1064] Kei-ichi Minami,et al. Change of drug excretory pathway by CCl4-induced liver dysfunction in rat. , 2007, Biochemical pharmacology.
[1065] C. Boyd,et al. The Distribution of Abcc6 in Normal Mouse Tissues Suggests Multiple Functions for this ABC Transporter , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[1066] C. Cass,et al. Polarized distribution of nucleoside transporters in rat brain endothelial and choroid plexus epithelial cells , 2005, Journal of neurochemistry.
[1067] N. Freimer,et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis , 1998, Nature Genetics.
[1068] D. Keppler,et al. Detection of the Human Organic Anion Transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in Liver and Hepatocellular Carcinoma , 2003, Laboratory Investigation.
[1069] S. Kliewer,et al. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption Published, JLR Papers in Press, September 6, 2007. , 2007, Journal of Lipid Research.
[1070] C. Endres,et al. The Role of the Equilibrative Nucleoside Transporter 1 (ENT1) in Transport and Metabolism of Ribavirin by Human and Wild-Type or Ent1(-/-) Mouse Erythrocytes , 2009, Journal of Pharmacology and Experimental Therapeutics.
[1071] Yong-Hae Han,et al. Current industrial practices of assessing permeability and P-glycoprotein interaction , 2006, The AAPS Journal.
[1072] K. Linton,et al. Repacking of the transmembrane domains of P‐glycoprotein during the transport ATPase cycle , 2001, The EMBO journal.
[1073] Hongbing Wang,et al. Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors. , 2003, Current drug metabolism.
[1074] E. Wallace,et al. Expression and localization of menkes and Wilson copper transporting ATPases in human placenta. , 2004, Placenta.
[1075] H. Kowarzyk. Structure and Function. , 1910, Nature.
[1076] M. Böhm,et al. The ATP-binding Cassette Transporter ABCG2 (BCRP), a Marker for Side Population Stem Cells, Is Expressed in Human Heart , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[1077] V. Ganapathy,et al. Localization of peptide transporter in nuclei and lysosomes of the pancreas , 1997, International journal of pancreatology : official journal of the International Association of Pancreatology.
[1078] Y. Sugiyama,et al. Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[1079] L. Malerød,et al. Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I. , 2005, Biochemical and biophysical research communications.
[1080] K. Köhrer,et al. Oligonucleotide microarray analysis of differential transporter regulation in the regenerating rat liver , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[1081] Y. Kato,et al. Involvement of Multidrug Resistance-Associated Protein 2 (Abcc2) in Molecular Weight-Dependent Biliary Excretion of β-Lactam Antibiotics , 2008, Drug Metabolism and Disposition.
[1082] V. Vollrath,et al. Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat. , 1996, Journal of hepatology.
[1083] Masaki Kobayashi,et al. Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells. , 2006, Biochimica et biophysica acta.
[1084] S. Bates,et al. Single-Nucleotide Polymorphism (SNP) Analysis in the ABC Half-Transporter ABCG2 (MXR/BCRP/ABCP1) , 2002, Cancer biology & therapy.
[1085] R. Béliveau,et al. Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. , 1996, The American journal of physiology.
[1086] J. Wess,et al. Role of acetylcholine and muscarinic receptors in serotonin-induced bronchoconstriction in the mouse , 2007, Journal of Molecular Neuroscience.
[1087] B. Blumberg,et al. Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. , 2006, Cancer research.
[1088] Richard J. Thompson,et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. , 1999, Gastroenterology.
[1089] R. Angeletti,et al. Interaction with PDZK1 Is Required for Expression of Organic Anion Transporting Protein 1A1 on the Hepatocyte Surface* , 2005, Journal of Biological Chemistry.
[1090] M. Perassolo,et al. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. , 2004, Biochemical pharmacology.
[1091] L. Pike. Rafts defined: a report on the Keystone symposium on lipid rafts and cell function Published, JLR Papers in Press, April 27, 2006. , 2006, Journal of Lipid Research.
[1092] Svetlana Lutsenko,et al. Function and regulation of human copper-transporting ATPases. , 2007, Physiological reviews.
[1093] L. Pawlikowska,et al. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport , 2006, Hepatology.
[1094] H. Saito,et al. Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2 , 2000, Pflügers Archiv.
[1095] R. Ueda,et al. MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer , 2008, Molecular Cancer Therapeutics.
[1096] I. Arias,et al. Intracellular Trafficking and Regulation of Canalicular ATP-Binding Cassette Transporters , 2000, Seminars in liver disease.
[1097] S. Cole,et al. Multidrug Resistance Protein , 1998, The Journal of Biological Chemistry.
[1098] Y. Sugiyama,et al. Functional analysis of nonsynonymous single nucleotide polymorphism type ATP-binding cassette transmembrane transporter subfamily C member 3 , 2008, Pharmacogenetics and genomics.
[1099] M. Makishima,et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. , 2001, Gastroenterology.
[1100] F. Lang,et al. Electrogenic Properties and Substrate Specificity of the Polyspecific Rat Cation Transporter rOCT1* , 1996, The Journal of Biological Chemistry.
[1101] K. Giacomini,et al. Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. , 2006, Journal of pharmaceutical sciences.
[1102] J. Mackey,et al. Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters. , 1999, Journal of the National Cancer Institute.
[1103] T. van der Poll,et al. Mice lacking the multidrug resistance protein 1 have a transiently impaired immune response during tuberculosis , 2002, Clinical and experimental immunology.
[1104] G. Mickisch. Multidrug Resistance , 1996, Der Urologe A.
[1105] N. Grishin,et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. , 2000, Science.
[1106] Y. Kanai,et al. Developmental changes in multispecific organic anion transporter 1 expression in the rat kidney. , 2000, Kidney international.
[1107] R. Keep,et al. Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[1108] Masahiko Watanabe,et al. Distinct spatio‐temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain , 2005, Journal of neurochemistry.
[1109] P. Dawson,et al. Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. , 1995, The Journal of clinical investigation.
[1110] D. Beier,et al. Impaired Organic Anion Transport in Kidney and Choroid Plexus of Organic Anion Transporter 3 (Oat3 (Slc22a8)) Knockout Mice* , 2002, The Journal of Biological Chemistry.
[1111] W. R. Wikoff,et al. Multiple organic anion transporters contribute to net renal excretion of uric acid. , 2008, Physiological genomics.
[1112] F. Suchy,et al. Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. , 1996, The American journal of physiology.
[1113] T. Greiner,et al. Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma , 2008, Molecular Cancer Therapeutics.
[1114] H. Kusuhara,et al. Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors. , 2004, Drug metabolism and pharmacokinetics.
[1115] Honggang Wang,et al. Membrane topology of the human breast cancer resistance protein (BCRP/ABCG2) determined by epitope insertion and immunofluorescence. , 2008, Biochemistry.
[1116] Y. Kanai,et al. Transport of ochratoxin A by renal multispecific organic anion transporter 1. , 1998, The Journal of pharmacology and experimental therapeutics.
[1117] Naoyuki Kamatani,et al. Genetic variations of the ABC transporter gene ABCB11 encoding the human bile salt export pump (BSEP) in a Japanese population. , 2009, Drug metabolism and pharmacokinetics.
[1118] P. Meier,et al. The Human Organic Anion Transporter 2 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α and Suppressed by Bile Acids , 2005, Molecular Pharmacology.
[1119] P. Langguth,et al. Caki-1 Cells as a Model System for the Interaction of Renally Secreted Drugs with OCT3 , 2008, Nephron Physiology.
[1120] G. Reid,et al. Protein kinase C activation downregulates human organic anion transporter 1-mediated transport through carrier internalization. , 2003, Journal of the American Society of Nephrology : JASN.
[1121] T. Kitano,et al. Allele frequencies of a SNP and a 27-bp deletion that are the determinant of earwax type in the ABCC11 gene. , 2008, Legal medicine.
[1122] Xingguo Cheng,et al. REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDES (OATPS) IN LIVER BY PROTOTYPICAL MICROSOMAL ENZYME INDUCERS THAT ACTIVATE DISTINCT TRANSCRIPTION FACTOR PATHWAYS , 2005, Drug Metabolism and Disposition.
[1123] C. Klaassen,et al. Tissue distribution and thyroid hormone regulation of Pept1 and Pept2 mRNA in rodents , 2006, Peptides.
[1124] A. Enomoto,et al. Function and localization of urate transporter 1 in mouse kidney. , 2004, Journal of the American Society of Nephrology : JASN.
[1125] O. Ogawa,et al. Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. , 2006, Journal of the American Society of Nephrology : JASN.
[1126] H. Koepsell,et al. Reduced Hepatic Uptake and Intestinal Excretion of Organic Cations in Mice with a Targeted Disruption of the Organic Cation Transporter 1 (Oct1 [Slc22a1]) Gene , 2001, Molecular and Cellular Biology.
[1127] J. Manautou,et al. Influence of Acetaminophen Vehicle on Regulation of Transporter Gene Expression During Hepatotoxicity , 2007, Journal of toxicology and environmental health. Part A.
[1128] M. Hidalgo,et al. Pharmacogenetics of ABCG2 and adverse reactions to gefitinib. , 2006, Journal of the National Cancer Institute.
[1129] G R Wilkinson,et al. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[1130] R. Ringseis,et al. Clofibrate treatment up-regulates novel organic cation transporter (OCTN)-2 in tissues of pigs as a model of non-proliferating species. , 2008, European journal of pharmacology.
[1131] A. Fagan,et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. , 2005, The Journal of clinical investigation.
[1132] Atsushi Ose,et al. Quantitative Investigation of the Role of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting Brain and Testis Penetration of Xenobiotic Compounds , 2008, Drug Metabolism and Disposition.
[1133] H. Denk,et al. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[1134] Zhe-Sheng Chen,et al. MRP8, ATP-binding Cassette C11 (ABCC11), Is a Cyclic Nucleotide Efflux Pump and a Resistance Factor for Fluoropyrimidines 2′,3′-Dideoxycytidine and 9′-(2′-Phosphonylmethoxyethyl)adenine* , 2003, Journal of Biological Chemistry.
[1135] T. Abe,et al. OATP1B1, OATP1B3, AND MRP2 ARE INVOLVED IN HEPATOBILIARY TRANSPORT OF OLMESARTAN, A NOVEL ANGIOTENSIN II BLOCKER , 2006, Drug Metabolism and Disposition.
[1136] M. Kimura,et al. Differential expression of multidrug resistance (mdr) and canalicular multispecific organic anion transporter (cMOAT) genes following extrahepatic biliary obstruction in rats , 1998, Biochemistry and molecular biology international.
[1137] Xingguo Cheng,et al. Tissue Distribution, Ontogeny, and Hormonal Regulation of Xenobiotic Transporters in Mouse Kidneys , 2009, Drug Metabolism and Disposition.
[1138] H. Rosing,et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[1139] D. Keppler,et al. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane , 1999, Hepatology.
[1140] Kelly A. Harmon,et al. The Role of Efflux and Uptake Transporters in N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, Lapatinib) Disposition and Drug Interactions , 2008, Drug Metabolism and Disposition.
[1141] Ning Li,et al. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[1142] C. Klaassen. Effect of Microsomal Enzyme Inducers on the Biliary Excretion of an Exogenous Load of Bilirubin in Newborn Rats 1 , 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[1143] C. Endres,et al. The Role of Nucleoside Transporters in the Erythrocyte Disposition and Oral Absorption of Ribavirin in the Wild-Type and Equilibrative Nucleoside Transporter 1(−/−) Mice , 2009, Journal of Pharmacology and Experimental Therapeutics.
[1144] R. Keep,et al. Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice , 2009, Journal of neurochemistry.
[1145] A. S. Gross,et al. The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects. , 2008, British journal of clinical pharmacology.
[1146] J. Schellens,et al. Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2) , 2005, Cancer Chemotherapy and Pharmacology.
[1147] H. Faulstich,et al. Identification of phalloidin uptake systems of rat and human liver. , 2004, Biochimica et biophysica acta.
[1148] Yoshinori Morita,et al. MDR1 Genotype-Related Pharmacokinetics of Digoxin After Single Oral Administration in Healthy Japanese Subjects , 2001, Pharmaceutical Research.
[1149] T. Ishikawa,et al. Functional Validation of the Genetic Polymorphisms of Human ATP-Binding Cassette (ABC) Transporter ABCG2: Identification of Alleles That Are Defective in Porphyrin Transport , 2006, Molecular Pharmacology.
[1150] P. Meier,et al. Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[1151] Jonathan C. Cohen,et al. ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile Published, JLR Papers in Press, June 1, 2005. DOI 10.1194/jlr.M500115-JLR200 , 2005, Journal of Lipid Research.
[1152] J. Verweij,et al. Interaction of Cisplatin with the Human Organic Cation Transporter 2 , 2008, Clinical Cancer Research.
[1153] G. Burckhardt,et al. Human Organic Anion Transporter 3 (hOAT3) can Operate as an Exchanger and Mediate Secretory Urate Flux , 2003, Cellular Physiology and Biochemistry.
[1154] G. Kullak-Ublick,et al. The Human Organic Cation Transporter-1 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α , 2006, Journal of Pharmacology and Experimental Therapeutics.
[1155] E. G. de la Concha,et al. Role of SLC22A4, SLC22A5, and RUNX1 genes in rheumatoid arthritis. , 2006, The Journal of rheumatology.
[1156] Russ B. Altman,et al. PharmGKB: the Pharmacogenetics Knowledge Base , 2002, Nucleic Acids Res..
[1157] P. Meier,et al. Localization of the Organic Anion Transporting Polypeptide 2 (Oatp2) in Capillary Endothelium and Choroid Plexus Epithelium of Rat Brain , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[1158] W. Elmquist,et al. Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux , 2003, Journal of Pharmacology and Experimental Therapeutics.
[1159] V. Vollrath,et al. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. , 2006, The Biochemical journal.
[1160] F. Russel,et al. Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. , 2005, American journal of physiology. Renal physiology.
[1161] R. Kim,et al. Polymorphisms in OATP-C , 2001, The Journal of Biological Chemistry.
[1162] H. Aburatani,et al. Characterization of the mouse Abcc12 gene and its transcript encoding an ATP-binding cassette transporter, an orthologue of human ABCC12. , 2003, Gene.
[1163] S. Teng,et al. Induction of ABCC3 (MRP3) by pregnane X receptor activators. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[1164] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[1165] L Landmann,et al. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. , 2001, Gastroenterology.
[1166] I. Hisatome,et al. Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans* , 2008, Journal of Biological Chemistry.
[1167] T. Abe,et al. Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes. , 2001, The Journal of pharmacology and experimental therapeutics.
[1168] B. Tuchweber,et al. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice. , 2003, Pharmacological research.
[1169] M. Erion,et al. Isolation of a family of organic anion transporters from human liver and kidney. , 2001, Biochemical and biophysical research communications.
[1170] Rachel J. Johnson,et al. Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[1171] S. Barros,et al. Activation of Protein Kinase Cζ Increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated Transport* , 2009, Journal of Biological Chemistry.
[1172] H. Friess,et al. Gender‐specific expression of liver organic anion transporters in rat , 2005, European journal of clinical investigation.
[1173] C. Enrich,et al. Concentrative nucleoside transporter (rCNT1) is targeted to the apical membrane through the hepatic transcytotic pathway. , 2002, Experimental cell research.
[1174] M. Pastor-Anglada,et al. SLC28 genes and concentrative nucleoside transporter (CNT) proteins. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[1175] G. Hooiveld,et al. Up‐regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down‐regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver , 1998, Hepatology.
[1176] D. Keppler,et al. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. , 1997, Journal of the American Society of Nephrology : JASN.
[1177] Association of SLC22A4/5 Polymorphisms with Steroid Responsiveness of Inflammatory Bowel Disease in Japan , 2008, Diseases of the colon and rectum.
[1178] G. Folkers,et al. Identification of steroid sulfate transport processes in the human mammary gland. , 2003, The Journal of clinical endocrinology and metabolism.
[1179] H. Endou,et al. Regulation by protein kinase C of organic anion transport driven by rat organic anion transporter 3 (rOAT3). , 2000, Life sciences.
[1180] M. Vore,et al. Translational Regulation of Rat Multidrug Resistance-Associated Protein 2 Expression Is Mediated by Upstream Open Reading Frames in the 5′ Untranslated Region , 2007, Molecular Pharmacology.
[1181] C. Klaassen,et al. Xenobiotic transporters: ascribing function from gene knockout and mutation studies. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[1182] F. Lang,et al. Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1 , 1996, FEBS letters.
[1183] G. Koren,et al. Investigating the potential role of multi-drug resistance protein (MRP) transporters in fetal to maternal glyburide efflux in the human placenta , 2008, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[1184] J. Rommens,et al. The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.
[1185] H. Daniel,et al. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology , 2004, Pflügers Archiv.
[1186] J. Manautou,et al. Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease , 2007, Toxicologic pathology.
[1187] C. Klaassen,et al. Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis. , 2007, Biochimica et biophysica acta.
[1188] A. Kastrati,et al. Lower Prevalence of the OCT2 Ser270 Allele in Patients with Essential Hypertension , 2006, Clinical and experimental hypertension.
[1189] T. Tanahashi,et al. Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies , 2008, Journal of Human Genetics.
[1190] Tohru Mizushima,et al. NorM, a Putative Multidrug Efflux Protein, of Vibrio parahaemolyticus and Its Homolog in Escherichia coli , 1998, Antimicrobial Agents and Chemotherapy.
[1191] H. Kusuhara,et al. P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION , 2005, Drug Metabolism and Disposition.
[1192] F. Russel,et al. Interaction of Nonsteroidal Anti-Inflammatory Drugs with Multidrug Resistance Protein (MRP) 2/ABCC2- and MRP4/ABCC4-Mediated Methotrexate Transport , 2007, Journal of Pharmacology and Experimental Therapeutics.
[1193] S. Masuda,et al. Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer , 2008, Drug Metabolism and Disposition.
[1194] A. Tall,et al. ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein* , 2001, The Journal of Biological Chemistry.
[1195] R. Evans,et al. Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice* , 2004, Journal of Biological Chemistry.
[1196] S. Masuda,et al. Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1–3 and Multidrug and Toxin Extrusion Family) , 2006, Journal of Pharmacology and Experimental Therapeutics.
[1197] K. Giacomini,et al. Na(+)-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. , 1997, The American journal of physiology.
[1198] K. Giacomini,et al. Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1). , 2000, The Journal of pharmacology and experimental therapeutics.
[1199] H. Endou,et al. Differential gene expression of organic anion transporters in male and female rats. , 2002, Biochemical and biophysical research communications.
[1200] G. Schmitz,et al. ATP-Binding Cassette Transporter A1 (ABCA1) in Macrophages: A Dual Function in Inflammation and Lipid Metabolism? , 2000, Pathobiology.
[1201] B. Sumegi,et al. Phenotypic manifestations of the OCTN2 V295X mutation: Sudden infant death and carnitine‐responsive cardiomyopathy in Roma families , 2004, American journal of medical genetics. Part A.
[1202] K. Hillgren,et al. Comparison of human and monkey peptide transporters: PEPT1 and PEPT2. , 2004, Molecular pharmaceutics.
[1203] Masahiko Watanabe,et al. ATP-Binding Cassette Transporter G2 Mediates the Efflux of Phototoxins on the Luminal Membrane of Retinal Capillary Endothelial Cells , 2006, Pharmaceutical Research.
[1204] E. Seidman,et al. Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[1205] R. Houwen,et al. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. , 2001, Journal of hepatology.
[1206] D. Keppler,et al. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. , 1994, The Journal of biological chemistry.
[1207] C. Klaassen,et al. Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility. , 2004, Biochemical and biophysical research communications.
[1208] J. Nezu,et al. Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1 , 1997, FEBS letters.
[1209] Y. Kato,et al. Involvement of Multidrug Resistance-Associated Protein 1 in Intestinal Toxicity of Methotrexate , 2009, Pharmaceutical Research.
[1210] M. Finegold,et al. Consequences of copper accumulation in the livers of the Atp7b-/- (Wilson disease gene) knockout mice. , 2006, The American journal of pathology.
[1211] G R Lankas,et al. Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. , 1997, Toxicology and applied pharmacology.
[1212] D. Shen,et al. MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents , 2009, Cancer Chemotherapy and Pharmacology.
[1213] P. Meier,et al. Functional analysis and androgen-regulated expression of mouse organic anion transporting polypeptide 1 (Oatp1) in the kidney. , 2001, Biochimica et biophysica acta.
[1214] S. Ito,et al. Prostaglandin transporter PGT is expressed in cell types that synthesize and release prostanoids. , 2002, American journal of physiology. Renal physiology.
[1215] F. Suchy,et al. Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. , 1981, Gastroenterology.
[1216] H. Daniel,et al. Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein. , 2002, American journal of physiology. Endocrinology and metabolism.
[1217] C. Higgins,et al. Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding* , 2003, The Journal of Biological Chemistry.
[1218] Fanfan Zhou,et al. The Role of N-Linked Glycosylation in Protein Folding, Membrane Targeting, and Substrate Binding of Human Organic Anion Transporter hOAT4 , 2005, Molecular Pharmacology.
[1219] L. Chinn,et al. ABCB1 Pharmacogenetics: Progress, Pitfalls, and Promise , 2007, Clinical pharmacology and therapeutics.
[1220] Kaoru Kobayashi,et al. Hepatocyte Nuclear Factor 1 Alpha is a Factor Responsible for the Interindividual Variation of OATP1B1 mRNA Levels in Adult Japanese Livers , 2007, Pharmaceutical Research.
[1221] A. Taniguchi,et al. A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout. , 2005, Arthritis and rheumatism.
[1222] A. Amoroso,et al. Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. , 2003, Biochemical and biophysical research communications.
[1223] J. Uitto,et al. Pseudoxanthoma elasticum: oxidative stress and antioxidant diet in a mouse model (Abcc6-/-). , 2008, The Journal of investigative dermatology.
[1224] J. Drewe,et al. Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. , 2000, Molecular pharmacology.
[1225] W. Gibb,et al. Expression and localisation of breast cancer resistance protein (BCRP) in human fetal membranes and decidua and the influence of labour at term. , 2008, Reproduction, fertility, and development.
[1226] U. Völker,et al. Multidrug resistance-related protein 2 genotype of the donor affects kidney graft function , 2009, Pharmacogenetics and genomics.
[1227] H. Daniel,et al. Cellular and molecular mechanisms of renal peptide transport. , 1997, The American journal of physiology.
[1228] M. L. Ruiz,et al. Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose. , 2009, Biochemical Pharmacology.
[1229] C. Klaassen,et al. Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[1230] H. Mohrenweiser,et al. Functional Consequences of Single Nucleotide Polymorphisms in the Human Organic Anion Transporter hOAT1 (SLC22A6) , 2005, Journal of Pharmacology and Experimental Therapeutics.
[1231] R. O. Oude Elferink,et al. Role of MRP2 and GSH in intrahepatic cycling of toxins. , 2001, Toxicology.
[1232] I. Arias,et al. Trafficking of canalicular ABC transporters in hepatocytes. , 2002, Annual review of physiology.
[1233] S. Yao,et al. Cloning of a human nucleoside transporter implicated in the Cellular uptake of adenosine and chemotherapeutic drugs , 1997, Nature Medicine.
[1234] R. Keep,et al. Role of PEPT2 in the Choroid Plexus Uptake of Glycylsarcosine and 5-Aminolevulinic Acid: Studies in Wild-Type and Null Mice , 2004, Pharmaceutical Research.
[1235] Yuichi Sugiyama,et al. Polymorphisms of OATP‐C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics , 2003, Clinical pharmacology and therapeutics.
[1236] Ya-li Liu,et al. Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[1237] S. Bandinelli,et al. The GLUT9 Gene Is Associated with Serum Uric Acid Levels in Sardinia and Chianti Cohorts , 2007, PLoS genetics.
[1238] P. Meier,et al. Expression of the hepatocyte Na+/bile acid cotransporter in Xenopus laevis oocytes. , 1990, The Journal of biological chemistry.
[1239] T. Rikiyama,et al. Farnesoid X receptor, hepatocyte nuclear factors 1α and 3β are essential for transcriptional activation of the liver-specific organic anion transporter-2 gene , 2006, Journal of Gastroenterology.
[1240] B. T. Hinton,et al. Organic Cation/Carnitine Transporter, OCTN2, Is Differentially Expressed in the Adult Rat Epididymis1 , 2002 .
[1241] M. P. Gallagher,et al. Subcellular Distribution and Membrane Topology of the Mammalian Concentrative Na+-Nucleoside Cotransporter rCNT1* , 2001, The Journal of Biological Chemistry.
[1242] Y. Kanai,et al. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. , 2004, Journal of pharmacological sciences.
[1243] J. Nezu,et al. Functional relevance of carnitine transporter OCTN2 to brain distribution of l‐carnitine and acetyl‐l‐carnitine across the blood–brain barrier , 2001, Journal of neurochemistry.
[1244] Conrad C. Huang,et al. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[1245] H. Yawo,et al. Immunohistochemical distribution and functional characterization of an organic anion transporting polypeptide 2 (oatp2) , 1999, FEBS letters.
[1246] D. Keppler,et al. Absence of the canalicular isoform of the MRP gene–encoded conjugate export pump from the hepatocytes in Dubin‐Johnson syndrome , 1996, Hepatology.
[1247] F. Döring,et al. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. , 1998, The Journal of clinical investigation.
[1248] H. Saito,et al. Gender differences in expression of organic cation transporter OCT2 in rat kidney , 1999, FEBS letters.
[1249] M. Imamura,et al. Expression profiles of various transporters for oligopeptides, amino acids and organic ions along the human digestive tract. , 2005, Biochemical pharmacology.
[1250] J. Mackey,et al. Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney. , 2007, American journal of physiology. Renal physiology.
[1251] J. Whitlock,et al. Induction of hepatic cytochrome P450 gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1989, Molecular biology & medicine.
[1252] K. Zatloukal,et al. Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. , 2003, Journal of hepatology.
[1253] D. Housman,et al. mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. , 1992, The Journal of biological chemistry.
[1254] J. Boyer,et al. Down‐regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis , 2004, Hepatology.
[1255] T. Cowan,et al. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity , 2000, Human mutation.
[1256] V. Schuster,et al. Identification and characterization of a prostaglandin transporter. , 1995, Science.
[1257] P. Gros,et al. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities , 1990, Molecular and cellular biology.
[1258] C. Klaassen,et al. Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[1259] Shigeki Sugiura,et al. ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS , 2005, Drug Metabolism and Disposition.
[1260] H. Kusuhara,et al. Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1. , 2002, Life sciences.
[1261] V. Ganapathy,et al. Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice. , 2007, Molecular genetics and metabolism.
[1262] W. R. Wikoff,et al. Organic anion transporter 3 contributes to the regulation of blood pressure. , 2008, Journal of the American Society of Nephrology : JASN.
[1263] Christian Funck-Brentano,et al. Digoxin pharmacokinetics and MDR1 genetic polymorphisms , 2003, European Journal of Clinical Pharmacology.
[1264] K. Takata,et al. Peptide Transporter in the Rat Small Intestine: Ultrastructural Localization and the Effect of Starvation and Administration of Amino Acids , 1999, The Histochemical Journal.
[1265] P. Neuvonen,et al. Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans , 2009, Pharmacogenetics and genomics.
[1266] H. Takikawa,et al. ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3)* , 2000, The Journal of Biological Chemistry.
[1267] B. Giros,et al. Organic Cation Transporter 3 (Slc22a3) Is Implicated in Salt-Intake Regulation , 2004, The Journal of Neuroscience.
[1268] H. Koepsell,et al. The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. , 2000, Journal of the American Society of Nephrology : JASN.
[1269] I. Rubio-Aliaga,et al. Peptide transporters and their roles in physiological processes and drug disposition. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[1270] K. Griffin,et al. Role of the peroxisome proliferator‐activated receptor in cytochrome P450 4A gene regulation , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[1271] F. Lammert,et al. Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. , 2002, Journal of hepatology.
[1272] K. Nakayama,et al. Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities. , 2003, Biochemical pharmacology.
[1273] A. Barton,et al. Investigation of the SLC22A4 gene (associated with rheumatoid arthritis in a Japanese population) in a United Kingdom population of rheumatoid arthritis patients. , 2005, Arthritis and rheumatism.
[1274] W. Stremmel,et al. Localization of the Wilson disease protein in murine intestine , 2008, Journal of anatomy.
[1275] A. Coop,et al. Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats. , 2007, Journal of pharmaceutical sciences.
[1276] Y. Sugiyama,et al. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1 , 1998 .
[1277] J. Unadkat,et al. The Breast Cancer Resistance Protein (Bcrp1/Abcg2) Limits Fetal Distribution of Glyburide in the Pregnant Mouse – An OPRU Network and UW SCOR Study , 2007 .
[1278] K. P. Brady,et al. A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse. , 1999, Genomics.
[1279] C. Klaassen,et al. Prominent Expression of Xenobiotic Efflux Transporters in Mouse Extraembryonic Fetal Membranes Compared with Placenta , 2008, Drug Metabolism and Disposition.
[1280] F. Suchy,et al. Sodium taurocholate cotransporting polypeptide is a serine, threonine phosphoprotein and is dephosphorylated by cyclic adenosine monophosphate , 1998, Hepatology.
[1281] M. Devoto,et al. Variants of OCTN1–2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis , 2006, Alimentary pharmacology & therapeutics.
[1282] A. Lumsden,et al. A novel Q378X mutation exists in the transmembrane transporter protein ABCC6 and its pseudogene: implications for mutation analysis in pseudoxanthoma elasticum , 2001, Journal of Molecular Medicine.